Your browser is no longer supported. Please, upgrade your browser.
Settings
AZN AstraZeneca PLC daily Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E37.85 EPS (ttm)0.88 Insider Own0.50% Shs Outstand2.53B Perf Week-1.01%
Market Cap84.07B Forward P/E14.70 EPS next Y2.26 Insider Trans0.00% Shs Float2.50B Perf Month6.77%
Income2.22B PEG- EPS next Q0.81 Inst Own12.20% Short Float1.15% Perf Quarter12.43%
Sales24.06B P/S3.49 EPS this Y128.90% Inst Trans12.74% Short Ratio4.67 Perf Half Y14.65%
Book/sh5.35 P/B6.21 EPS next Y-8.50% ROA3.70% Target Price34.50 Perf Year11.67%
Cash/sh1.84 P/C18.10 EPS next 5Y-1.00% ROE13.90% 52W Range26.61 - 34.58 Perf YTD2.40%
Dividend0.90 P/FCF- EPS past 5Y-16.70% ROI11.50% 52W High-3.90% Beta0.75
Dividend %2.71% Quick Ratio0.80 Sales past 5Y-5.80% Gross Margin82.20% 52W Low24.86% ATR0.53
Employees61500 Current Ratio0.90 Sales Q/Q-11.20% Oper. Margin15.00% RSI (14)58.08 Volatility1.54% 1.56%
OptionableYes Debt/Eq1.30 EPS Q/Q-100.40% Profit Margin9.20% Rel Volume0.63 Prev Close33.50
ShortableYes LT Debt/Eq1.22 EarningsJul 28 BMO Payout108.10% Avg Volume6.15M Price33.23
Recom2.60 SMA20-1.33% SMA507.00% SMA20010.56% Volume3,892,100 Change-0.81%
Jul-12-16Initiated Argus Hold
Apr-12-16Downgrade Goldman Neutral → Sell
Mar-15-16Downgrade Jefferies Buy → Hold
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-08-16Downgrade HSBC Securities Buy → Hold
Jan-19-16Upgrade Barclays Underweight → Equal Weight
Dec-01-15Upgrade Morgan Stanley Underweight → Overweight
Nov-02-15Downgrade Nordea Buy → Hold
Oct-20-15Downgrade Credit Suisse Neutral → Underperform
Sep-18-15Upgrade Bryan Garnier Neutral → Buy
Jul-31-15Upgrade Swedbank Neutral → Buy
Jul-02-15Upgrade Berenberg Hold → Buy
Apr-15-15Initiated Societe Generale Buy
Sep-22-10Reiterated Barclays Capital Equal Weight $225 → $230
Jul-29-10Downgrade Standpoint Research Buy → Hold $60
Jun-30-10Upgrade Jefferies Underperform → Hold
Jan-13-10Upgrade Credit Suisse Underperform → Neutral
Nov-16-09Initiated Deutsche Securities Hold
Nov-12-09Initiated Barclays Capital Equal Weight
Nov-09-09Downgrade JP Morgan Neutral → Underweight
Aug-25-16 01:18PM  Pfizer Inks a $1.6 Billion Deal with AstraZeneca at Investopedia
11:04AM  AstraZenecas Recent Product Developments
10:04AM  Changes in AstraZenecas Profitability in 2Q16
09:19AM  A Closer Look at AstraZeneca Following the Sale of its Molecule Antibiotics Business to Pfizer
08:04AM  AstraZeneca and Its Oncology Segments Growth in 2Q16
06:45AM  MedImmune won't be impacted by AstraZeneca sale of antibiotic business to Pfizer at bizjournals.com
Aug-24-16 05:11PM  Pfizer on buying spree with AstraZeneca antibiotics deal
04:52PM  AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit
02:42PM  Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
01:25PM  AstraZeneca to sell antibiotic pills business to Pfizer
11:53AM  European Markets Mixed as Volatility Hits 17-Month Low
11:04AM  Performance of AstraZenecas RI&A Segment in 2Q16
10:19AM  [$$] AstraZeneca and Pfizer strike $1.6bn antibiotics deal at Financial Times
10:04AM  Why AstraZeneca Continued to Lose Market Share in ING Segment
09:45AM  AstraZeneca to sell molecule antibiotics business to Pfizer
08:50AM  AstraZeneca selling antibiotic unit to Pfizer for $725M at bizjournals.com
08:04AM  How Crestor Weakened AstraZenecas CVMD Segment in 2Q16
07:14AM  Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
03:44AM  Pfizer to buy antibiotics business from AstraZeneca Reuters
02:50AM  Pfizer Picks Up AstraZeneca's Antibiotics Business
02:15AM  AstraZeneca to sell antibiotics business to Pfizer Reuters
02:09AM  Pfizer to Buy Antibiotics From AstraZeneca for $725 Million at Bloomberg
Aug-23-16 07:04PM  Performance of AstraZenecas Growth Platforms in 2Q16
06:32PM  AstraZeneca sells part of antibiotics unit to Pfizer AFP
05:04PM  Why AstraZeneca Reported Negative Growth in 2Q16
03:13PM  Is AstraZenecas Valuation Improving Compared to Peers?
11:04AM  Whats Challenging Novos Leadership in the US Diabetes Space?
08:59AM  Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track
08:58AM  Pfizer Has Had A Busy M&A Year...Or Has It?
Aug-22-16 02:47PM  Stocks Struggle for Direction as Jackson Hole Conference Looms
01:14PM  How Did Novos Diabetes and Obesity Care Segment Perform in 1H16?
10:39AM  Understanding Medivations Premium Valuation
10:16AM  July FOMC Minutes: Brexit Impact on US Not as Bad as Expected
09:04AM  Inside the Performance of Sanofis Human Vaccines Segment in 2Q16
Aug-21-16 11:41AM  3 Reasons Medivation Is the Juiciest Target in Biotech at Motley Fool
Aug-20-16 09:01AM  3 High-Yielding Healthcare Stocks I'm Not Buying at Motley Fool
Aug-19-16 10:23AM  Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
10:21AM  3 Reasons Inovio Pharmaceuticals Inc. Stock Could Rise at Motley Fool
Aug-17-16 05:05PM  Inside Sanofis Valuation Changes
Aug-15-16 02:44PM  Top 3 Research Reports for August 15, 2016
09:06AM  What Are Mercks Key Diabetes Products?
Aug-12-16 11:41AM  Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010 at Motley Fool
01:00AM  AstraZeneca Transcends Brexit Woes on Pound Slump, Rivals Flop at Bloomberg
Aug-11-16 07:01PM  AstraZeneca wins UK cost approval for longer use of heart drug Reuters
09:06AM  Understanding Growth Contributors for Pfizer
Aug-10-16 06:40PM  After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers? at Motley Fool
04:41PM  Lilly Breast Cancer Drug Study Rolls On, Pushing Back Launch Date
10:41AM  AstraZeneca bets another $140 mln on Moderna's "messenger" drugs
06:15AM  [$$] Inovio Pharma May Be Burning Too Hot at Barrons.com
Aug-09-16 03:40PM  How Did Novo Nordisk Perform across Geographies in 1H16?
03:37PM  Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial
07:40AM  Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals at MarketWatch
02:42AM  AstraZeneca drug selumetinib fails in lung cancer study Reuters
02:23AM  AstraZeneca Cancer Drug Selumetinib Fails in Lung Trial at Bloomberg
02:01AM  AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer PR Newswire
Aug-08-16 12:45PM  Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further at 24/7 Wall St.
10:32AM  Why Merck's Lung Cancer Success Won't Last at Barrons.com
Aug-05-16 01:49PM  Bristol-Myers: All Is Not Lost at Barrons.com
01:00PM  [$$] Nektar Therapeutics' Sweet Pipeline at Barrons.com
12:17PM  Why AstraZeneca (AZN) Stock Is Higher Today
12:01PM  Bristol-Myers Squibb's Loss Is "A Big Win" For Merck at Barrons.com
10:43AM  AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
Aug-04-16 02:39PM  ETFs with exposure to AstraZeneca Plc : August 4, 2016
Aug-03-16 05:13PM  Generics Keeping The Pressure On Big Pharma
11:44AM  Increasing Risk of CVDs to Help Salvage the Global Hypercholesterolemia Drugs Market Through 2020, Says Technavio Business Wire
11:26AM  AstraZeneca Plc :AZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 02:51AM  Hutchison China MediTech Limited (Chi-Med) Reports Interim Results for the Six Months Ended June 30, 2016, Provides 2016 Financial Guidance and Updates Shareholders on Key Clinical Programs Business Wire
Aug-01-16 03:32AM  Chi-Med and AstraZeneca Amend Co-development Agreement to Accelerate Savolitinib Global Development Program Business Wire
Jul-29-16 03:27PM  Legg Mason Introduces International High Dividend, Low Vol ETF
09:16AM  AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
Jul-28-16 02:13PM  AstraZeneca (AZN) Stock Up After Q2 Earnings, Revenue Beat +8.72%
10:54AM  Astrazeneca beats 2Q profit forecasts
10:11AM  Stocks Flat As Facebook Flies And Ford Falls at Forbes
10:08AM  How GoPro, Suncor, and 3 Other Companies Performed During Their Latest Quarters at Insider Monkey
08:34AM  AstraZeneca a bid target again? CEO says someone may spot value
08:16AM  Pharma earnings roundup
06:48AM  AstraZeneca helped by new drugs as cholesterol pill fades
06:43AM  AstraZeneca Pledges Sales Boost Even as Strong Dollar Bites at Bloomberg
05:43AM  AstraZeneca a takeover target again? CEO not commenting
05:01AM  AstraZeneca Earnings, Sales Edge Above Forecasts
03:47AM  [$$] AstraZeneca Posts $3 Million Loss at The Wall Street Journal
03:10AM  AstraZeneca says 2Q earnings fell 22 percent
02:13AM  AstraZeneca earnings hit by waning cholesterol drug sales
02:10AM  AstraZenecas Earnings Meet Estimates as New Drug Sales Rose at Bloomberg
Jul-27-16 11:05AM  Bristol-Myers Squibbs 2Q16 Estimates: Other Segments
09:12AM  Mercks 2Q16 Estimates: Expect Operational Growth in Revenues
09:09AM  Which Growth Platforms Will Drive AstraZenecas 2Q16 Earnings?
Jul-26-16 09:08AM  Why Analysts Think AstraZenecas Revenues Will Fall in 2Q16
04:21AM  What Can Investors Expect from AstraZenecas 2Q16 Earnings?
Jul-24-16 11:48AM  [$$] New drugs aim to kill cancer cells by destabilising their DNA at Financial Times
Jul-22-16 12:58PM  European Stock Markets Mixed After Signs of Brexit Damage
Jul-21-16 04:20PM  Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly at Motley Fool
04:16PM  Relypsa Getting Acquired By Swiss Partner Seeking U.S. Entry
12:05PM  Why Shares of Relypsa Are Soaring Today at Motley Fool
Jul-20-16 08:42AM  Your inhaler's watching you: drugmakers race for smart devices Reuters
01:20AM  Indian Firms Get Approval for Generics of AstraZeneca Drug at Bloomberg
Jul-19-16 06:58PM  Judge refuses to block generic versions of AstraZeneca's Crestor Reuters
06:54PM  AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
05:51PM  AstraZeneca Fails to Keep Generic Crestor Rivals Off Market at Bloomberg
04:27PM  FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis PR Newswire
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of respiratory, inflammation, autoimmune, cardiovascular, metabolic, oncology, infection, neuroscience, and gastrointestinal diseases worldwide. Its marketed products comprise Accolate, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp, Duaklir Genuair, Eklira Genuair/Tudorza/Bretaris, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Rhinocort, Symbicort pMDI, and Symbicort Turbuhaler for respiratory, inflammation, and autoimmunity diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor2, Plendil, Seloken/Toprol-XL, Tenormin3, and Zestril4 for cardiovascular disease; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic disease. The company's marketed products also include Arimidex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex, as well as Casodex, Cosudex for oncology disease; Fluenz/FluMist, Fluenz Tetra/FluMist Quadrivalent1, Merrem/Meronem2, Synagis3, and Zinforo4 for infection disease; Diprivan, EMLA, Movantik/Moventig, Naropin, Seroquel IR, Seroquel XR, Vimovo1, Xylocaine, and Zomig for neuroscience disease; and Losec/Prilosec and Nexium for gastrointestinal disease. It primarily serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 146 projects, of which 125 are in the clinical phase of development. It has collaboration agreements with Celgene Corporation; Immunocore Limited; Eli Lilly and Company; Heptares Ltd.; Foundation Medicine, Inc., French National Institute of Health and Medical Research (Inserm); and FibroGen and Astellas. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
EBAY eBay Inc. daily Stock Chart
EBAY [NASD]
eBay Inc.
IndexS&P 500 P/E18.73 EPS (ttm)1.67 Insider Own7.40% Shs Outstand1.12B Perf Week2.69%
Market Cap35.26B Forward P/E15.02 EPS next Y2.09 Insider Trans-0.37% Shs Float1.04B Perf Month0.10%
Income1.99B PEG3.26 EPS next Q0.44 Inst Own84.20% Short Float2.23% Perf Quarter29.93%
Sales8.79B P/S4.01 EPS this Y330.80% Inst Trans-2.08% Short Ratio2.13 Perf Half Y29.61%
Book/sh5.64 P/B5.56 EPS next Y10.66% ROA10.20% Target Price31.09 Perf Year19.76%
Cash/sh7.17 P/C4.37 EPS next 5Y5.74% ROE29.90% 52W Range21.52 - 31.79 Perf YTD14.05%
Dividend- P/FCF40.67 EPS past 5Y3.30% ROI13.00% 52W High-1.42% Beta1.14
Dividend %- Quick Ratio4.50 Sales past 5Y-1.30% Gross Margin78.40% 52W Low45.63% ATR0.52
Employees11600 Current Ratio4.50 Sales Q/Q-79.10% Oper. Margin27.10% RSI (14)75.00 Volatility1.22% 1.26%
OptionableYes Debt/Eq0.00 EPS Q/Q-76.60% Profit Margin22.00% Rel Volume0.68 Prev Close31.25
ShortableYes LT Debt/Eq1.40 EarningsJul 20 AMC Payout0.00% Avg Volume10.90M Price31.34
Recom2.60 SMA201.19% SMA5013.04% SMA20020.94% Volume7,451,200 Change0.29%
Jul-21-16Reiterated The Benchmark Company Buy $29 → $33
Jul-21-16Reiterated RBC Capital Mkts Sector Perform $28 → $31
Jul-21-16Reiterated Monness Crespi & Hardt Buy $29 → $32
Jul-21-16Reiterated Mizuho Neutral $26 → $31
Jul-21-16Reiterated Canaccord Genuity Hold $27 → $28
Jul-21-16Reiterated Axiom Capital Buy $30 → $34
Jun-23-16Initiated Maxim Group Buy $36
Apr-27-16Reiterated RBC Capital Mkts Sector Perform $29 → $28
Apr-19-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-29-16Downgrade Barclays Equal Weight → Underweight $28 → $25
Feb-16-16Reiterated Axiom Capital Buy $34 → $30
Jan-28-16Reiterated The Benchmark Company Buy $29 → $28
Jan-28-16Reiterated RBC Capital Mkts Sector Perform $30 → $29
Jan-28-16Reiterated Monness Crespi & Hardt Buy $31 → $29
Jan-28-16Reiterated Canaccord Genuity Hold $28 → $26
Jan-15-16Initiated Susquehanna Positive $34
Oct-22-15Reiterated Topeka Capital Markets Buy $68 → $32
Oct-22-15Reiterated RBC Capital Mkts Sector Perform $29 → $30
Oct-22-15Reiterated Mizuho Neutral $30 → $29
Sep-24-15Reiterated JP Morgan Neutral $33 → $32
Aug-25-16 01:50PM  Amazon's Autos: eBay, TrueCar in the Headlights, Says Morgan Stanley at Barrons.com
11:04AM  What Can You Expect from eBay in the Future?
10:04AM  Why Is eBays Revenue Trend so Encouraging?
09:33AM  Billionaire Jacob Rothschild Loves These Five Stocks at Insider Monkey
06:35AM  [$$] Facebook Messenger chatbots - a disappointing Google alternative at Financial Times
Aug-24-16 05:07PM  Is eBays Turnaround Plan Actually Working?
05:07PM  Why E-commerce Trends Are Looking Positive
03:39PM  4 Stocks to Watch Before the Market Opens Tomorrow
11:32AM  Traders looking for pop in eBay this week
09:05AM  Does eBay Have 1.7 Million Counterfeit Products for Sale? at 24/7 Wall St.
Aug-23-16 11:58AM  Forcerank Expects Amazon and Priceline to Outperform Other Ecommerce Names this Week
11:37AM  7 Ways To Re-Energize Your Team at Forbes
Aug-22-16 05:00PM  StubHub Becomes Official Ticket Marketplace of Boston College Athletics Business Wire
07:46AM  These 5 Rocket Stocks Look Ready for Blastoff
Aug-21-16 10:44PM  Alibaba Blends E-Commerce and Social Media at Bloomberg
09:03AM  [$$] How unwanted second-hand books became big business at Financial Times
Aug-20-16 05:02PM  Losing PayPal May Have Actually Helped eBay
Aug-19-16 01:08PM  A Year Since the PayPal Spin-Off, and eBay Is Still Going Strong
09:55AM  Does eBay Have Over 400,000 Counterfeit Items? at 24/7 Wall St.
Aug-18-16 01:00AM  Tech industry's legal shield is feeling the heat Reuters
Aug-17-16 08:11AM  US Consumer Price Inflation Remains Unchanged
Aug-16-16 07:25PM  eBay, Inc's Best Business Segment in 2016 So Far at Motley Fool
11:05AM  What Are Analysts Recommendations for Alibaba?
06:07AM  Fed Rate Hike Prospects Dampened By Retail Sales And Inflation Release?
Aug-15-16 04:46PM  George Soros sells off Apple stake during the second quarter, slashes Amazon holding at MarketWatch
07:47AM  Investors Seeking To Buy Stockpile Gift Cards Can Now Do It On eBay
Aug-14-16 03:54PM  Robert Olstein's Best Performing Investments Include eBay
Aug-13-16 06:28PM  How Hedge Funds Top Bets on eCommerce Are Performing So Far This Year at Insider Monkey
Aug-12-16 06:07PM  Silicon Valley tech firms pledge to fight illegal wildlife trading at Silicon Beat
01:19PM  Here's How Etsy and eBay Are Trying to Stop Illegal Online Wildlife Trafficking at TheStreet
11:05AM  Why Amazons Lofty Valuation Is Warranted
Aug-11-16 04:32PM  Alibaba closes out a trifecta of e-commerce earnings beats at MarketWatch
04:21PM  Walmarts Jet Acquisition: Why Amazon Shouldnt Worry Too Much
04:21PM  Why Is Walmart Acquiring Jet?
03:42PM  Why Shares of eBay Rose 33% in July at Motley Fool
09:38AM  Bill Miller formally severs ties with Legg Mason at MarketWatch
09:25AM  Amazon, eBay and Alibaba Face Problem as Counterfeit Goods Reach $1.7 Trillion at 24/7 Wall St.
Aug-10-16 01:49PM  3 Stocks New To Argus' Selector Focus List
01:34PM  Can "Promoted Listings" Drive Revenues For eBay? at Forbes
Aug-09-16 10:10AM  In race for profitability, Shyp doubles down on business customers at bizjournals.com
Aug-08-16 04:33PM  [video]Global X Study Shows How Millennials Invest
Aug-07-16 01:09PM  [$$] Alphabet's transformation is more complex than ABC at Financial Times
Aug-05-16 04:32PM  Retail Sector's Disappointing Q2 Earnings Season
09:05AM  What Are Analysts Recommendations for Alibaba?
09:04AM  How Amazon Is Addressing Its Elephant in the Room
Aug-03-16 04:01PM  Elon Musk's Career so Far
12:19PM  Etsy Starts to Shine as Its Hidden Gems Surface
12:00PM  Karen Harvey Consulting Group Announces The 3rd Annual Fashion Tech Forum (FTF) At Duggal Greenhouse In Brooklyn On October 13th, 2016 PR Newswire
10:19AM  Bitcoin Prices Fall, Hackers Reportedly Stole Bitcoins Worth $65 Million
Aug-02-16 11:58PM  Meg Whitman backs Hillary Clinton, calls Trump a demagogue at MarketWatch
12:35PM  Uber China to Sell to Didi Chuxing
10:57AM  Amazon Handedly Beat Analysts 2Q Estimates
08:18AM  Uber Joins Other U.S. Firms Stymied by China at MarketWatch
Aug-01-16 06:34PM  Jerome Dodson Added to 9 Recent Investments in 2nd Quarter
04:25PM  3 men charged with selling $200,000 in stolen razor blades
11:56AM  [$$] Uber deal with Didi is latest US bumpy ride in China at Financial Times
09:49AM  Buy These 5 Big Stocks for August Gains
Jul-31-16 02:05AM  Why eBay's Rally Should Get Investors Excited
Jul-29-16 09:29AM  EBay Arbitrage and Airline Competition at Bloomberg
09:00AM  eBay Announces the Winners of Its First Annual SHINE Awards Business Wire
08:00AM  eBay Partners With Designer Rachel Zoe to Culminate Summer of Choice and Send Shoppers Back to School in Style Business Wire
05:44AM  These hot tech stocks sizzle
Jul-28-16 01:20PM  Did You Just Buy a Fake at eBay? at 24/7 Wall St.
Jul-27-16 01:04PM  EBAY INC Financials
12:25PM  Amazon's Cloud Computing and Retail Success Are Key to 2Q
11:27AM  Activist investors are on the prowl for new targets at CNBC
11:04AM  What Are Analysts Recommendations for eBay?
10:31AM  Exclusive: Alibaba, eBay, CVC bid for Polish auction site Allegro - sources Reuters
09:04AM  eBay: Upbeat Guidance Reinstates Investors Confidence
Jul-26-16 01:34PM  Citi Says eBay Could Be Target for Alphabet, Stock Rises
12:50PM  eBay Can Be M&A Fodder for Alphabet or Others, Says Citi at Barrons.com
11:04AM  What Took a Toll on eBays Margins?
09:30AM  The Zacks Analyst Blog Highlights: Intel, Microsoft, eBay, IBM and Netflix
09:30AM  Isn't It Obvious? How To Be More Overt at Forbes
09:04AM  How eBays Core Platform and Classifieds Performed in 2Q16
Jul-25-16 12:55PM  ETFs with exposure to eBay, Inc. : July 25, 2016
11:36AM  Is Now the Right Time to Buy eBay Stock? at Motley Fool
11:05AM  Why eBays StubHub Is the New Growth Engine
09:30AM  The Zacks Analyst Blog Highlights: Yahoo, Verizon, EBay, Sotheby and AT&T
09:05AM  How eBay Managed to Increase Active Buyers in 2Q16
08:58AM  [$$] Yahoo: a history of the internet in 5 acts at Financial Times
Jul-23-16 06:55PM  eBay, AMD Head the List of Nasdaq Stocks Hitting 52-Week Highs Friday at Insider Monkey
01:11PM  3 Key Lessons From Netflix, Domino's Pizza: IBD Investing Show
Jul-22-16 04:49PM  Who Won and Lost on the Nasdaq This Week? Bloomberg TV Weighs In at TheStreet
04:39PM  Who Got Best Of Visa-PayPal Deal? 'Too Early To Tell'
02:04PM  eBay: 2Q16 Top Line Driven by StubHub and Classifieds
11:49AM  eBay, Inc. :EBAY-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016
07:16AM  eBay getting slight boost from Brexit at MarketWatch
01:03AM  What Drove eBays 2Q16 Bottom Line?
Jul-21-16 09:31PM  EBay's plan to stay relevant: Artificial intelligence at CNBC +10.89%
06:03PM  Stocks Lose Steam; Breakouts From eBay, Domino's
05:12PM  EBay Stock Hits Record High As Earnings Hint At 'Cash Cougar'
05:10PM  EBAY INC Files SEC form 10-Q, Quarterly Report
05:00PM  Biz Break: eBay shines after results; smartwatch sales retreat at Silicon Beat
04:56PM  eBay Is No Amazon, But It's In Better Shape Than Before
04:52PM  Stock Market Today: eBay and Dominos Jump as the Broad Market Declines at Motley Fool
04:40PM  PayPal Posts 15% Rise In Second Quarter Sales, Partners With Visa at Forbes
04:30PM  Qualcomm, Halliburton, eBay, Intel Price Targets Raised After Earnings
03:54PM  Google: Currency Headwinds Could Impact the Top Line
03:42PM  EBay Rewards Investors Following 2Q Earnings and Upbeat Guidance
eBay Inc. operates e-commerce platforms that connect various buyers and sellers worldwide. Its platforms enable sellers to organize and offer inventory for sale; and buyers to find and buy it virtually anytime and anywhere. The company's Marketplace platforms include its online marketplace at ebay.com and the eBay mobile apps; and StubHub platforms comprise its online ticket platform at stubhub.com and the StubHub mobile apps, which enable fans to purchase tickets to the games, concerts, and theater shows. Its Classifieds platforms include a collection of brands, such as Mobile.de, Kijiji, Gumtree, Marktplaats, eBay Classifieds, and others that offer online classifieds and help people find whatever they are looking for in their local communities. The company platforms enable users to find, buy, sell, and pay for items through various online, mobile, and offline channels, which include retailers, distributors, liquidators, import and export companies, auctioneers, catalog and mail-order companies, classifieds, directories, search engines, commerce participants, shopping channels, and networks. eBay Inc. was founded in 1995 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Todd Jeremy PaulSVP, EMEAAug 10Option Exercise0.0032,935084,065Aug 12 05:06 PM
Lee Jae HyunSVP, Asia PacificJul 27Sale31.533,222101,590107,154Jul 28 08:15 PM
Lee Jae HyunSVP, Asia PacificJul 26Sale31.0310,601328,949110,376Jul 27 06:40 PM
FISHER STEPHENSVP, CTOJul 25Option Exercise21.6437,223805,57797,032Jul 27 06:58 PM
TIERNEY THOMAS JDirectorJul 25Option Exercise9.858,00078,80025,545Jul 27 07:13 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Option Exercise22.6313,608307,94948,605Jul 27 06:19 PM
Lee Jae HyunSVP, Asia PacificJul 25Sale30.741,16735,878120,977Jul 27 06:40 PM
Yetto Kristin ASVP, Chief People OfficerJul 25Sale30.7917,596541,83419,346Jul 27 06:34 PM
Doerger Brian J.VP, Chief Accounting OfficerJul 25Sale30.5623,958732,26424,647Jul 27 06:19 PM
TIERNEY THOMAS JDirectorJul 25Sale30.658,000245,20017,545Jul 27 07:13 PM
SWAN ROBERT HOLMESDirectorJul 25Sale30.6550,0001,532,340425,288Jul 27 07:06 PM
FISHER STEPHENSVP, CTOJul 25Sale30.6553,3891,636,16959,176Jul 27 06:58 PM
Schenkel Scott F.SVP, Chief Financial OfficerJul 17Option Exercise0.001,768092,875Jul 18 08:27 PM
WENIG DEVINPresident and CEOJul 17Option Exercise0.005,8950449,754Jul 18 07:55 PM
Lawton III Harry ASVP, N.A.Jun 15Option Exercise0.0042,723039,075Jun 17 07:57 PM
Lee Jae HyunSVP, Asia PacificJun 15Option Exercise0.003,1270122,144Jun 17 07:53 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerJun 15Option Exercise0.005,732029,461Jun 17 07:50 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 15Option Exercise0.004,559037,376Jun 17 07:46 PM
Todd Jeremy PaulSVP, EMEAJun 15Option Exercise0.0014,501057,098Jun 17 07:42 PM
WENIG DEVINPresident and CEOJun 15Option Exercise0.0013,0870450,688Jun 17 08:18 PM
Schenkel Scott F.SVP, Chief Financial OfficerJun 15Option Exercise0.006,253094,370Jun 17 08:15 PM
Huber Marie OhSVP, GC & SecretaryJun 15Option Exercise0.0031,556029,055Jun 17 08:10 PM
Yetto Kristin ASVP, Chief People OfficerJun 15Option Exercise0.0015,543041,926Jun 17 08:04 PM
FISHER STEPHENSVP, CTOJun 15Option Exercise0.007,295079,149Jun 16 08:42 PM
Doerger Brian J.VP, Chief Accounting OfficerJun 08Option Exercise0.0011,388038,760Jun 09 05:22 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerMay 27Sale24.2425,000605,89823,729Jun 01 04:28 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Option Exercise16.6814,474241,42641,846May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 24Sale24.0814,474348,53427,372May 24 08:58 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Option Exercise16.6820,000333,60047,372May 10 07:49 PM
Doerger Brian J.VP, Chief Accounting OfficerMay 09Sale24.0320,000480,65027,372May 10 07:49 PM
Yetto Kristin ASVP, Chief People OfficerApr 29Sale24.1110,630256,30428,343May 03 07:29 PM
Yetto Kristin ASVP, Chief People OfficerApr 01Option Exercise0.0027,861052,553Apr 05 08:01 PM
WENIG DEVINPresident and CEOApr 01Option Exercise0.0078,0130477,120Apr 05 07:59 PM
Todd Jeremy PaulSVP, EMEAApr 01Option Exercise0.0017,168052,659Apr 05 07:49 PM
Schenkel Scott F.SVP, Chief Financial OfficerApr 01Option Exercise0.0025,0330100,013Apr 05 07:48 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerApr 01Option Exercise0.0010,973053,026Apr 05 07:47 PM
Lee Jae HyunSVP, Asia PacificApr 01Option Exercise0.0016,1830117,850Apr 05 07:36 PM
FISHER STEPHENSVP, CTOApr 01Option Exercise0.0010,919077,552Apr 05 07:35 PM
Doerger Brian J.VP, Chief Accounting OfficerApr 01Option Exercise0.0025,327036,892Apr 05 07:33 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Option Exercise20.9428,204590,592111,323Mar 01 06:53 PM
PITTMAN RAYMOND JSVP, Chief Product Officer,Feb 26Sale24.3378,5371,910,77232,786Mar 01 06:53 PM
TIERNEY THOMAS JDirectorFeb 17Option Exercise6.694,42429,59719,901Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 17Sale23.084,424102,10615,477Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Option Exercise6.693,57623,92319,053Feb 18 07:01 PM
TIERNEY THOMAS JDirectorFeb 16Sale23.003,57682,24815,477Feb 18 07:01 PM
PRESSLER PAUL SDirectorFeb 01Buy23.944,180100,05410,448Mar 04 08:16 PM
SWAN ROBERT HOLMESDirectorFeb 01Sale23.7450,0001,187,065474,469Feb 03 05:23 PM
Doerger Brian J.VP, Chief Accounting OfficerDec 15Option Exercise0.0013,928018,833Dec 17 07:02 PM
PITTMAN RAYMOND JSVP, Chief Product Officer, MaDec 15Option Exercise0.00131,9130149,518Dec 17 06:42 PM
PRESSLER PAUL SDirectorNov 30Buy29.125,140149,6905,140Dec 01 04:57 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 30Sale29.2520,000585,00088,534Dec 02 06:27 PM
ANDERSON FRED DDirectorNov 09Option Exercise9.853,50334,50517,480Nov 12 06:24 PM
ANDERSON FRED DDirectorNov 09Sale29.003,503101,58713,977Nov 12 06:24 PM
Yetto Kristin ASVP, Human ResourcesNov 05Sale29.136,638193,36614,025Nov 09 05:29 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 03Option Exercise14.867,677114,080136,211Nov 05 05:41 PM
Lee Jae HyunSVP, eBay Marketplaces AsiaNov 03Sale28.8827,677799,389108,534Nov 05 05:41 PM
PITTMAN RAYMOND JSVP, Chief Product OfficerOct 30Sale27.9821,000587,58017,605Nov 03 06:48 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 26Option Exercise21.2038,714820,72393,826Oct 27 09:15 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 26Sale27.9078,7752,197,44715,051Oct 27 09:15 PM
FISHER STEPHENSVP & Chief Technology OfficerOct 15Option Exercise0.00106,5510106,551Oct 19 05:45 PM
Schenkel Scott F.SVP and CFOOct 15Option Exercise0.005,907039,341Oct 16 07:34 PM
WENIG DEVINPresident and CEOOct 15Option Exercise0.0013,8980312,322Oct 16 08:02 PM
WENIG DEVINPresident and CEOOct 14Option Exercise0.00151,7080377,586Oct 16 08:02 PM
Schenkel Scott F.SVP and CFOOct 14Option Exercise0.0059,459064,460Oct 16 07:34 PM
Doerger Brian J.VP, Chief Accounting OfficerAug 28Sale27.074,658126,1014,905Sep 01 08:13 PM
EPD Enterprise Products Partners L.P. daily Stock Chart
EPD [NYSE]
Enterprise Products Partners L.P.
Index- P/E21.15 EPS (ttm)1.25 Insider Own0.30% Shs Outstand2.11B Perf Week-2.29%
Market Cap55.73B Forward P/E18.35 EPS next Y1.44 Insider Trans0.00% Shs Float1.40B Perf Month-7.34%
Income2.54B PEG3.58 EPS next Q0.32 Inst Own35.90% Short Float0.61% Perf Quarter-3.79%
Sales23.09B P/S2.41 EPS this Y-14.40% Inst Trans5.42% Short Ratio1.96 Perf Half Y14.63%
Book/sh10.42 P/B2.53 EPS next Y14.30% ROA5.10% Target Price32.85 Perf Year-3.15%
Cash/sh0.05 P/C491.01 EPS next 5Y5.91% ROE12.20% 52W Range19.00 - 30.10 Perf YTD3.21%
Dividend1.60 P/FCF- EPS past 5Y16.90% ROI8.30% 52W High-12.29% Beta0.88
Dividend %6.06% Quick Ratio0.60 Sales past 5Y-4.30% Gross Margin14.80% 52W Low38.95% ATR0.55
Employees6800 Current Ratio0.80 Sales Q/Q-20.80% Oper. Margin15.60% RSI (14)34.87 Volatility1.57% 2.18%
OptionableYes Debt/Eq1.05 EPS Q/Q-3.20% Profit Margin11.00% Rel Volume0.67 Prev Close26.32
ShortableYes LT Debt/Eq1.01 EarningsJul 28 BMO Payout124.80% Avg Volume4.36M Price26.40
Recom1.80 SMA20-2.87% SMA50-6.45% SMA2003.01% Volume2,943,901 Change0.30%
Aug-18-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-11-16Initiated Bernstein Outperform $33
Apr-29-16Downgrade Seaport Global Securities Buy → Neutral $30
Jan-20-16Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-06-16Initiated Scotia Howard Weil Sector Outperform $31
Nov-03-15Reiterated Argus Buy $44 → $38
Jul-31-15Reiterated Stifel Buy $38 → $34
Jul-23-15Initiated DA Davidson Buy $36
Jun-16-15Initiated Sun Trust Rbsn Humphrey Buy
May-19-15Initiated Wunderlich Buy $38
May-19-15Initiated Deutsche Bank Buy $38
Jan-20-15Reiterated Oppenheimer Outperform $44 → $39
Jun-03-14Initiated Global Hunter Securities Buy $83
May-02-14Reiterated Stifel Buy $75 → $78
May-02-14Reiterated RBC Capital Mkts Outperform $71 → $80
May-02-14Reiterated Oppenheimer Outperform $74 → $86
Mar-20-14Reiterated Stifel Buy $70 → $75
Jan-31-14Reiterated Argus Buy $70 → $75
Jan-06-14Reiterated Deutsche Bank Buy $70 → $74
Aug-02-13Resumed Oppenheimer Outperform $67 → $71
Aug-25-16 11:04AM  How Enterprise Products Partners Yield Compares with Peers
10:04AM  Enterprise Products: Trading Close to Historical Average Yield
09:54AM  With MLP 'Recovery Emerging,' Citi Names 6 Value, 3 Thematic Picks at Barrons.com
08:04AM  How Enterprise Products Partners Maintains a Stable Capital Mix
07:20AM  5 Companies That Should Consider Kicking Their CEOs to the Curb at Motley Fool
Aug-24-16 11:04AM  A Look at Enterprise Products Key Upcoming Capital Projects
10:04AM  Is Enterprise Products Partners Well Placed for Inorganic Growth?
08:04AM  LPG Exports: A Key Focus for Enterprise Products Partners
Aug-23-16 04:04PM  Enterprise Partners Gas Gathering, Processing: Less Contribution
03:52PM  Corvex's Meister threatens to nominate 10 of his employees to Williams' board
03:04PM  Which Segment Drives Enterprise Products Partners Performance?
12:41PM  Whats Ahead for Enterprise Products Partners Stock?
10:00AM  Does Enterprise Products Partners LP's Interest in Williams Companies Inc. Make Sense? at Motley Fool
Aug-22-16 06:32PM  13F Filings: Thumbs Up Or Thumbs Down For Gladiators? at Forbes
01:41PM  Corvex's Keith Meister Wants to Place 10 Directors on Williams Cos. (WMB) Board
09:16AM  Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking at Insider Monkey
Aug-21-16 01:00PM  How the WTI Crude Oil Price Affects Shale Oil Producers at Motley Fool
11:13AM  3 Top Stocks You Can Buy and Hold for the Next Decade at Motley Fool
Aug-20-16 10:09AM  3 Energy Stocks to Buy with Dividend Yields Above 5% at Motley Fool
09:25AM  Rig Count Rises by 10, Huge Short Covering in Crude Market at 24/7 Wall St.
Aug-19-16 03:42PM  Williams Merger with Enterprise Products Looks Unlikely at Barrons.com
12:25PM  [$$] Williams faces investor revolt after spurning Enterprise offer at Financial Times
Aug-18-16 07:58PM  PRESS DIGEST- Financial Times - Aug 19 Reuters
05:45PM  Why Williams Companies, Canadian Solar, and Advanced Micro Devices Jumped Today at Motley Fool
02:33PM  Williams Cos. (WMB) Stock Surges on Rejected Enterprise Takeover Bid
01:48PM  What the Kinder Morgan Upgrade Indicates at 24/7 Wall St.
01:34PM  Enterprise Products approached Williams over acquisition -sources
01:32PM  Williams Rebuffs Enterprise Merger Bid, Financial Times Says
10:11AM  Morgan Stanley On Midstream Energy: 1 Upgrade, 3 Downgrades
09:23AM  3 High-Yield ETFs to Buy Today at Motley Fool
08:45AM  Top Analyst Upgrades and Downgrades: Cisco, Enterprise Products, JC Penney, Kinder Morgan, NetApp, Priceline, Digital Ally and More at 24/7 Wall St.
06:46AM  Enterprise Products downgraded by Morgan Stanley
Aug-16-16 09:50AM  Returns of Midstream Stocks with High and Low Implied Volatility
Aug-15-16 05:44PM  Leon Cooperman's Omega Buys Netflix, Citigroup, Shire
09:15AM  Enterprise Products Partners to Participate in Citi MLP / Midstream Infrastructure Conference Business Wire
Aug-13-16 10:02AM  5 Dividend Stocks to Put on Your Shopping List at Motley Fool
Aug-11-16 09:53AM  Enterprise (EPD), Occidental Bring Natural Gas Facility Online
Aug-10-16 07:38AM  Mariner Investment Group Powers Up On Energy Stocks In Q2 at Insider Monkey
Aug-09-16 01:04PM  ENTERPRISE PRODUCTS PARTNERS L P Financials
12:03PM  Returns of Midstream Stocks with High and Low Implied Volatility
10:30AM  Enterprise Products Partners President Randy Fowler Interviewed by Advisor Access Marketwired
Aug-06-16 09:40AM  Oil Rig Count Up by 7 Last Week, Hedge Funds Scooping Up Short Contracts at 24/7 Wall St.
Aug-04-16 02:52PM  ETFs with exposure to Enterprise Products Partners LP : August 4, 2016
08:35AM  Did Plains All American Pipeline Beat 2Q16 Earnings Estimates?
06:05AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
Aug-03-16 03:00PM  Enterprise and Occidental Petroleum Begin Service at Delaware Basin Gas Processing Facility Business Wire
01:41PM  Targa Resources: 3 LPG cargoes canceled in past two months
12:15PM  Which Segment Drove ONEOKs 2Q16 Earnings Growth?
10:45AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 10-Q, Quarterly Report
Aug-02-16 11:45AM  Enterprise Products Partners LP :EPD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016
Aug-01-16 11:07AM  How Enterprise Products 2Q Results Impacted Its Stock Performance
09:09AM  Will Additions to Global Oil Supply Benefit Enterprise Products?
Jul-30-16 09:35AM  Oil Rig Count Up by 3 Last Week, Hedge Funds Pile Into Short Contracts at 24/7 Wall St.
Jul-29-16 02:20PM  Enterprise Products to ship first export from new Houston ethane facility at bizjournals.com
01:16PM  NGL Pipelines and Services Segment Drove EPDs 2Q Earnings Growth
01:16PM  Enterprise Products Reports Strong Liquid Pipeline Volumes for 2Q
11:09AM  Enterprise Product Partners (EPD) Misses on Q2 Earnings
Jul-28-16 05:00PM  Will Tesoro Logistics Post Higher 2Q16 Earnings?
04:12PM  Foreign Buyers of U.S. Propane Dont Want What They Paid For at Bloomberg
12:45PM  Enterprise Products Partners Produces Yet Another Consistent Earnings Result in the Second Quarter at Motley Fool
11:43AM  Enterprise to export first ethane cargo from Houston terminal in August
11:24AM  Enterprise to export first cargo of ethane from Houston terminal in August
10:00AM  Enterprise Products Partners LP Earnings Call scheduled for 10:00 am ET today
07:07AM  Q2 2016 Enterprise Products Partners LP Earnings Release - Before Market Open
06:21AM  Enterprise Products misses 2Q profit forecasts
06:03AM  ENTERPRISE PRODUCTS PARTNERS L P Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Fin
06:00AM  Enterprise Reports Results for Second Quarter 2016 Business Wire
Jul-27-16 09:55AM  Why Merrill Lynch Sees Enterprise Products and Top MLPs Rising Higher After Earnings at 24/7 Wall St.
Jul-26-16 01:12PM  Returns of Midstream Stocks with High and Low Implied Volatility
02:09AM  Empired Ltd. :EPD-AU: Earnings Analysis: For the six months ended December 31, 2015 : July 26, 2016
Jul-25-16 09:40AM  2 Dividend Stocks to Buy on Sale at Motley Fool
Jul-24-16 02:13PM  [$$] Landscape shifts for pipeline operators at Financial Times
12:00PM  3 Dividend Stocks You Don't Have to Babysit at Motley Fool
Jul-23-16 01:06PM  3 Stocks That Retirees Should Consider Buying Today at Motley Fool
Jul-22-16 01:12PM  How Are Analysts Rating EPD Ahead of Its 2Q16 Earnings Release?
01:12PM  Will Enterprise Products Partners Benefit from the Global Oil Supply?
01:12PM  What Will Fuel Enterprise Products Partners Growth Going Forward?
01:12PM  Inside Enterprise Products Key Strategy
Jul-20-16 04:08PM  Why Are the Gathering and Processing Businesses Pressuring Enterprise Products?
04:08PM  How Are EPDs Segments Expected to Perform in 2Q16?
04:08PM  Enterprise Products Is Expected to Report Higher 2Q16 Earnings
12:28PM  These 3 Stocks Just Raised Their Dividends at Motley Fool
Jul-19-16 04:56PM  After 4-Month Run-Up, Are MLPs Still Cheap? at Barrons.com
03:51PM  Bahnsen: Enterprise Products is the cream of the crop nam...
08:30AM  Enterprise Adds Propylene Exports to Service Offerings at Houston Ship Channel Facility Business Wire
Jul-17-16 10:05AM  More Upgraded Expectations for Kinder Morgan and Enterprise at 24/7 Wall St.
Jul-16-16 09:50AM  Oil Rig Count Up by 6 Last Week, Hedge Funds Turn Long on Crude, Distillates at 24/7 Wall St.
09:35AM  3 Stocks to Buy With Dividends Yielding More Than 5% at Motley Fool
Jul-15-16 09:05AM  Why 43% of Analysts Rate Kinder Morgan Buy before 2Q16 Results
Jul-14-16 10:33AM  7 Dividend Hikes In 7 Days
Jul-13-16 02:04PM  1 Stock to Own in Energy at Motley Fool
09:53AM  PAA Aims to Lower Cost of Capital and Improve Coverage
Jul-12-16 06:19PM  Firms scrap July US LPG cargo loadings due to low spot prices -sources Reuters
03:28PM  Kinder Morgan Is Expected to Report Lower 2Q16 Earnings
12:00PM  5 Top Pipeline Stocks to Buy in 2016 at Motley Fool
10:08AM  Pioneer Paid Final Settlement by Enterprise Products Partners
08:05AM  3 Dividend Stocks That Prove Boring Is Beautiful at Motley Fool
Jul-11-16 10:15AM  Enterprise Makes Final Payment for EFS Midstream Assets Business Wire
09:50AM  RBC Sees MLPs in a New Trading Range: 4 Top Picks Now at 24/7 Wall St.
Jul-09-16 09:35AM  Oil Rig Count Up by 10 Last Week, Hedge Funds Add to Short Positions at 24/7 Wall St.
Enterprise Products Partners L.P., a master limited partnership, provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products. The company operates through NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services segments. The NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, as well as NGL export docks and related services. It operates approximately 19,500 miles of NGL pipelines; NGL and related product storage facilities; 15 NGL fractionators; and a liquefied petroleum gas export terminal and NGL import facility. The Crude Oil Pipelines & Services segment operates approximately 5,400 miles of crude oil pipelines and related operations; and crude oil storage and marine terminals located in Oklahoma and Texas, as well as a fleet of 478 tractor-trailer tank trucks used to transport crude oil. It also engages in crude oil marketing activities. The Natural Gas Pipelines & Services segment operates approximately 19,100 miles of natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming. It leases underground salt dome natural gas storage facilities in Texas and Louisiana; owns an underground salt dome storage cavern in Texas; and markets natural gas. The Petrochemical & Refined Products Services segment operates propylene fractionation and related operations, including 674 miles of pipelines; butane isomerization complex, associated deisobutanizer units, and related pipeline assets; and octane enhancement and high purity isobutylene production facilities. It also operates refined products pipelines of approximately 4,200 miles; and terminals, as well as provides refined products marketing and marine transportation services. The company was founded in 1968 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARTH CARIN MARCYDirectorFeb 12Buy20.525,000102,6005,000Feb 17 04:06 PM
MCMAHEN CHARLES EDirectorFeb 12Buy19.9910,000199,90097,554Feb 12 04:13 PM
Montgomery William CDirectorFeb 11Buy19.6910,000196,90036,500Feb 11 06:48 PM
WILLIAMS RANDA DUNCANDirectorJan 04Buy26.113,830,256100,007,9843,330,619Jan 04 05:47 PM
ANDRESS THURMONDirectorDec 22Buy25.102,50062,74247,552Dec 22 06:20 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.307,040149,952469,493Dec 07 04:26 PM
TEAGUE AJChief Operating OfficerDec 07Buy21.2923,475499,7831,389,300Dec 07 04:26 PM
Montgomery William CDirectorDec 07Buy21.2510,000212,50026,500Dec 07 04:15 PM
FOWLER W RANDALLChief Administrative OfficerDec 07Buy21.515,000107,550741,083Dec 07 04:08 PM
HACKETT JAMES TDirectorDec 02Buy24.5025,000612,50025,000Dec 02 04:10 PM
HACKETT JAMES TDirectorDec 02Buy24.50100,0002,450,000216,497Dec 02 04:10 PM
Bulawa Bryan F.SVP & Chief Financial OfficerNov 16Option Exercise16.1410,000161,350125,574Nov 17 04:34 PM
TEAGUE AJChief Operating OfficerSep 28Buy23.466,400150,1441,364,581Sep 29 04:27 PM
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
VRX [NYSE]
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-2.86 Insider Own2.30% Shs Outstand345.47M Perf Week6.51%
Market Cap10.74B Forward P/E3.99 EPS next Y7.80 Insider Trans2.71% Shs Float332.63M Perf Month32.35%
Income-988.40M PEG- EPS next Q1.79 Inst Own66.80% Short Float9.20% Perf Quarter15.40%
Sales10.32B P/S1.04 EPS this Y-133.00% Inst Trans20.37% Short Ratio1.02 Perf Half Y-61.45%
Book/sh15.35 P/B2.03 EPS next Y19.24% ROA-2.00% Target Price44.39 Perf Year-86.32%
Cash/sh2.47 P/C12.60 EPS next 5Y11.07% ROE-17.00% 52W Range18.55 - 245.82 Perf YTD-69.41%
Dividend- P/FCF8.24 EPS past 5Y4.40% ROI3.70% 52W High-87.35% Beta0.10
Dividend %- Quick Ratio1.10 Sales past 5Y54.60% Gross Margin74.70% 52W Low67.60% ATR1.77
Employees22000 Current Ratio1.40 Sales Q/Q-68.30% Oper. Margin7.70% RSI (14)67.83 Volatility5.63% 5.80%
OptionableYes Debt/Eq5.87 EPS Q/Q- Profit Margin-9.60% Rel Volume1.33 Prev Close30.54
ShortableYes LT Debt/Eq5.81 EarningsAug 09 BMO Payout- Avg Volume30.06M Price31.09
Recom2.90 SMA2020.62% SMA5031.36% SMA200-42.07% Volume39,591,200 Change1.80%
Aug-17-16Upgrade Morgan Stanley Equal-Weight → Overweight $33 → $42
Aug-15-16Upgrade Mizuho Underperform → Neutral $11 → $25
Aug-10-16Reiterated RBC Capital Mkts Sector Perform $31 → $36
Aug-10-16Reiterated Piper Jaffray Underweight $19 → $22
Aug-09-16Reiterated Rodman & Renshaw Buy $90 → $81
Jun-23-16Downgrade JP Morgan Overweight → Neutral
Jun-08-16Reiterated Stifel Buy $65 → $55
Jun-08-16Reiterated RBC Capital Mkts Sector Perform $58 → $33
Jun-08-16Reiterated Mizuho Underperform $18 → $11
May-03-16Reiterated Rodman & Renshaw Buy $105 → $102
Apr-12-16Reiterated RBC Capital Mkts Sector Perform $69 → $65
Apr-11-16Reiterated Rodman & Renshaw Buy $118 → $105
Mar-21-16Downgrade Mizuho Neutral → Underperform $70 → $18
Mar-21-16Downgrade Barclays Overweight → Equal Weight $135 → $34
Mar-16-16Reiterated Stifel Buy $200 → $65
Mar-16-16Reiterated Rodman & Renshaw Buy $150 → $118
Mar-16-16Reiterated RBC Capital Mkts Sector Perform $85 → $69
Mar-16-16Reiterated Canaccord Genuity Hold $75 → $40
Mar-16-16Downgrade Nomura Buy → Neutral $175 → $60
Mar-16-16Downgrade CIBC Sector Perform → Sector Underperform
Aug-25-16 04:02PM  Mylan offers price plan to help patients but its programs are still short on details at MarketWatch
01:29PM  [$$] Mylan: pen is not mightier at Financial Times
11:13AM  Here's A Reason Why Valeant (VRX) Stock Is Climbing Today
11:10AM  The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book
10:39AM  Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
09:21AM  Valeant's Management Continues To Take The Right Steps
08:31AM  How Mylan And Pfizer Could Cause A Major Biotech Backlash at Forbes
07:28AM  Mylan says it will expand programs that lower EpiPen costs
Aug-24-16 04:06PM  Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Aug-23-16 06:13PM  Valeant Pays up for New CFO Herendeen at The Wall Street Journal
05:03PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation
03:01PM  4 Big-Name Investment Funds That Strongly Believe in a Valeant Pharmaceuticals Turnaround at Motley Fool
12:39PM  Concordia's Uncanny Comparisons to Valeant Continue (Unfortunately) at The Wall Street Journal
10:30AM  Mylan: In EpiPen Controversy, Shades of Valeant at Barrons.com
10:10AM  Stock Market News for August 23, 2016
09:20AM  Blog Coverage Valeant Pharma Appoints New CEO
08:22AM  Valeants stock soars as investors cheer poaching of Zoetis CFO at MarketWatch
01:00AM  Pharming Convene an Extraordinary General Meeting of Shareholders PR Newswire
12:07AM  [$$] A Window of Opportunity Cracks Open at Valeant at The Wall Street Journal
Aug-22-16 06:54PM  Stocks Calm As Crude Plunges; Busy Day For Medical Sector +8.80%
06:22PM  Concordia Healthcare Says Chunk Of CEO's Shares Sold In Margin Call at Forbes
05:57PM  Why Syngenta, Valeant Pharmaceuticals, and BioMarin Pharmaceutical Jumped Today at Motley Fool
04:35PM  Raging Capital Double-Shorting Valeant, Goes Long AFI, CAVM, Others at Insider Monkey
04:31PM  Valeant Bonds Rise on New CFO Choice at Barrons.com
04:05PM  Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise
03:41PM  Valeant's C-Suite Sees Another Shake-Up
03:18PM  Valeant Pharmaceuticals: Three Reasons Its New CFO is the Right Choice at Barrons.com
02:45PM  7 Red Flags of an Imminent Company Meltdown
01:16PM  Valeant Pharmaceuticals (VRX) Appoints New CFO, Stock Gains 7.2%
01:16PM  Valeant Shares Rise on New CFO Appointment at TheStreet
12:53PM  What you need to know on Wall Street right now
12:21PM  Valeant, attempting to normalize operations, names new CFO
11:50AM  Why the Market is Cheering Valeant's New CFO at Barrons.com
10:52AM  Executive Shuffling, Bullish Write-ups, and Analyst Rating Changes: Heres Why These 5 Stocks Are Trending at Insider Monkey
10:47AM  [$$] A Window of Opportunity Cracks Open at Valeant at The Wall Street Journal
10:25AM  Valeant Gains Momentum With New CFO Appointment at 24/7 Wall St.
10:21AM  Jim Cramer -- Valeant Investors Should Welcome a High-Quality CFO
10:05AM  Allergan Makes an Eye-Opening Acquisition at Motley Fool
07:39AM  Valeant names Paul Herendeen as its new CFO at MarketWatch
07:39AM  Valeant (VRX) Stock Climbs, Hires Zoetis' Herendeen as CFO
07:00AM  Valeant hires Zoetis's Paul Herendeen as CFO
06:33AM  Valeant names Paul Herendeen as new CFO at MarketWatch
06:11AM  Valeant names former Zoetis executive Paul Herendeen as CFO
06:09AM  Valeant Picks New CFO From Zoetis in Ongoing Company Shakeup at Bloomberg
06:06AM  Valeant poached a new CFO from the animal-health company Zoetis
06:00AM  Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer PR Newswire
06:00AM  Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer CNW Group
Aug-21-16 09:33PM  Valeant Is Said to Hire Zoetis Paul Herendeen as CFO at Bloomberg
09:10PM  Valeant has reportedly poached a new CFO from the animal-health company Zoetis
07:15PM  Pershing Square Cuts Positions to Fight Losses (VRX, ZTS) at Investopedia
02:20PM  [$$] Pharmaceuticals: Staying power at Financial Times
12:04PM  [$$] US doctors waste millions on branded medicines at Financial Times
Aug-20-16 12:01AM  [$$] Hedge Funds Snap Up Banks, Unload Apple at Barrons.com
Aug-19-16 04:19PM  Hunting For Biotech Stocks? Understand The Earnings Formula First
03:41PM  T. Rowe Price Sues Valeant Pharmaceuticals For Fraud (TROW, VRX) at Investopedia
02:42PM  Big Money Really Wants Nothing to Do With Valeant Pharmaceuticals -- Here's Proof at Motley Fool
01:31PM  T. Rowe Price sues Valeant Pharmaceuticals, alleging 'fraudulent scheme' at bizjournals.com
01:28PM  'If you ever saw Wolves of Wall Street well that was sorta what some of us saw at Philidor'
12:27PM  Here's the meltdown Bill Ackman had when he found out what was going on at Valeant
10:33AM  Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC
10:21AM  Valeant Stock Down on Lawsuit by T. Rowe, Alters Credit Loan
10:10AM  Company News for August 19, 2016
08:56AM  A.M. Roundup: Hedge Fund Icon Sees "Biggest Bond Bubble Ever"; Changes At Edward Jones at Barrons.com
12:20AM  [$$] Valeant Again Able to Loosen Debt Terms at The Wall Street Journal
Aug-18-16 05:25PM  CANADA STOCKS-TSX slips as energy boost offset by banks, Valeant
04:34PM  T. Rowe Price sues Valeant over "fraudulent scheme" Reuters
04:00PM  JAIL STOCKS CRASH: Here's what you need to know
03:59PM  [$$] Valeant Able to Loosen Debt Terms at The Wall Street Journal
03:37PM  Valeants Debt Agreement Comes With Freedom to Miss Forecast at Bloomberg
03:06PM  Valeant's Feel-Good Moments Don't Last at Bloomberg
02:37PM  Why T. Rowe Price Is Suing Valeant Now
01:23PM  [$$] T Rowe Price sues Valeant for vast fraud at Financial Times
01:21PM  Valeant (VRX) Stock Falls on T. Rowe Price Lawsuit
01:04PM  VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Financials
12:36PM  Wells Fargo Analyst Maris Weighs In on Valeant (VRX) Lawsuit on CNBC
12:21PM  Oh look, another nasty problem for Valeant
12:14PM  Valeant sued by T. Rowe Price, claiming fraud at MarketWatch
11:50AM  [$$] T. Rowe Price Sues Valeant, Alleging 'Fraudulent Scheme' at The Wall Street Journal
11:43AM  T. Rowe Price sues Valeant
11:31AM  Why Valeant Pharmaceuticals is Tanking at Barrons.com
11:24AM  Valeant Pharmaceuticals Accused of Fraud in T. Rowe Price Suit
11:24AM  Valeant Pharmaceuticals Accused of Fraud in T. Rowe Lawsuit at Bloomberg
10:46AM  CANADA STOCKS-TSX nearly flat as energy stocks gain offset by telecoms, banks
10:38AM  Managing Your Swing Positions/Trades Better
10:21AM  Valeants Climb Offsets Financials as Canada Stocks Fluctuate
10:03AM  Valeant Climbs After Lenders Agree to Amend Credit Line: Chart at Bloomberg
09:38AM  Stocks Rise as Walmart Tops Estimates, Fed Speculation Continues
09:31AM  Stocks to Watch: Wal-Mart, Valeant, SunEdison, Cisco, Auris Medical at The Wall Street Journal
09:17AM  LPC: Valeant lenders agree to loan amendment to loosen covenants Reuters
09:04AM  Valeants Plan to Reduce Debt
08:37AM  Valeant amends credit facility for second time in six months Reuters
08:26AM  Valeant (VRX) Stock Higher on Credit Facility Amendment
08:15AM  Valeant Gets Lenders Blessing to Loosen Debt Requirements at Bloomberg
08:11AM  Valeant's stock jumps after credit facility amendment approved at MarketWatch
08:00AM  Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment PR Newswire
08:00AM  Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment CNW Group
Aug-17-16 06:15PM  Why Caesars Entertainment, Och-Ziff Capital Management, and Valeant Pharmaceuticals Jumped Today at Motley Fool +12.78%
04:26PM  Valeant Upgraded; Urban Outfitters In Buy Range On Q2 Beat, PT Hike
04:24PM  This private investor document perfectly shows why people are sick and tired of hedge funds
04:22PM  Valeant Upgraded Again As Restructuring Plans Impress
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KARABELAS ARGERIS NDirectorAug 11Buy24.654,00098,60020,726Aug 12 04:37 PM
Ross Thomas W. Sr.DirectorJun 13Buy24.404,00097,60021,882Jun 27 03:40 PM
PAPA JOSEPH CCHAIRMAN & CEOJun 10Buy24.48202,0004,944,9602,442,199Jun 13 06:47 AM
Pearson J. MichaelChief Executive OfficerNov 05Sale78.481,297,399101,825,9701,514,664Nov 09 05:24 PM
Farmer Ronald HaroldDirectorOct 21Buy181.601,500272,39515,532Oct 22 05:09 PM
LYB LyondellBasell Industries N.V. daily Stock Chart
LYB [NYSE]
LyondellBasell Industries N.V.
IndexS&P 500 P/E8.58 EPS (ttm)9.20 Insider Own18.58% Shs Outstand406.56M Perf Week1.06%
Market Cap32.09B Forward P/E8.17 EPS next Y9.66 Insider Trans-2.72% Shs Float336.62M Perf Month1.02%
Income4.10B PEG- EPS next Q2.34 Inst Own76.30% Short Float2.67% Perf Quarter-2.99%
Sales29.48B P/S1.09 EPS this Y20.00% Inst Trans-2.56% Short Ratio2.70 Perf Half Y-0.49%
Book/sh14.68 P/B5.38 EPS next Y1.61% ROA17.50% Target Price88.17 Perf Year0.43%
Cash/sh5.12 P/C15.41 EPS next 5Y-0.82% ROE61.80% 52W Range67.69 - 95.46 Perf YTD-7.27%
Dividend3.40 P/FCF15.02 EPS past 5Y-11.60% ROI30.00% 52W High-17.30% Beta1.76
Dividend %4.31% Quick Ratio1.40 Sales past 5Y-4.50% Gross Margin21.60% 52W Low16.62% ATR1.72
Employees13000 Current Ratio2.30 Sales Q/Q-19.90% Oper. Margin18.70% RSI (14)58.54 Volatility2.19% 2.27%
OptionableYes Debt/Eq1.45 EPS Q/Q-9.30% Profit Margin13.90% Rel Volume0.70 Prev Close78.09
ShortableYes LT Debt/Eq1.35 EarningsJul 29 BMO Payout34.60% Avg Volume3.33M Price78.94
Recom2.60 SMA203.54% SMA502.95% SMA200-3.02% Volume2,333,100 Change1.09%
Jun-27-16Downgrade RBC Capital Mkts Outperform → Sector Perform $100 → $84
Jun-23-16Downgrade JP Morgan Overweight → Neutral $100 → $80
Jun-13-16Downgrade Cowen Outperform → Market Perform $105 → $87
Apr-27-16Downgrade Nomura Buy → Neutral
Apr-05-16Downgrade Atlantic Equities Neutral → Underweight
Feb-03-16Downgrade RBC Capital Mkts Top Pick → Outperform $105 → $95
Jan-11-16Downgrade Credit Agricole Outperform → Underperform
Nov-25-15Reiterated Cowen Outperform $98 → $105
Oct-12-15Downgrade Macquarie Outperform → Neutral
Sep-17-15Reiterated Deutsche Bank Hold $100 → $95
Sep-11-15Initiated Bernstein Outperform $110
Sep-01-15Reiterated Cowen Outperform $115 → $98
May-08-15Initiated Standpoint Research Buy
Apr-28-15Reiterated RBC Capital Mkts Top Pick $111 → $123
Apr-27-15Reiterated Jefferies Hold $85 → $99
Apr-27-15Reiterated Deutsche Bank Hold $96 → $105
Apr-27-15Reiterated Barclays Overweight $105 → $115
Mar-13-15Initiated Argus Hold
Feb-13-15Downgrade Deutsche Bank Buy → Hold $96
Feb-04-15Reiterated RBC Capital Mkts Top Pick $102 → $105
Aug-23-16 04:15PM  CF Industries shares rise nearly 5 pct on UBS upgrade at CNBC
Aug-19-16 08:10AM  LyondellBasell Poised on Expansion Actions, Headwinds Remain
Aug-18-16 02:11PM  Argus Believes Oil Price Volatility A Headwind For LyondellBasell
Aug-16-16 10:10AM  Stock Market News for August 16, 2016
08:10AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : August 16, 2016
Aug-15-16 10:34AM  ETFs with exposure to LyondellBasell Industries NV : August 15, 2016
10:10AM  Stock Market News for August 15, 2016
Aug-11-16 03:33PM  Why Did Albemarles 2Q16 Revenue Miss Analyst Expectations?
11:28AM  Billionaire Ray Dalio Loads Up On Lyondell, Mining Stocks in Q2 at Insider Monkey
09:30AM  Zacks Industry Outlook Highlights: Eastman Chemical, LyondellBasell Industries, Methanex, CF Industries Holdings and Mosaic
Aug-10-16 11:04AM  Why Did LyondellBasells Technology Segments Revenue Rise in Q2?
09:04AM  Why LYBs Refining Segment Posted an Earnings Loss in Q2
Aug-09-16 03:47PM  Chemical Industry Stock Outlook - Aug 2016
11:05AM  LYBs Intermediates and Derivatives Revenue Also Fell in 2Q16
09:05AM  Why LYBs Olefins and Polyolefins EAI Revenue Fell in 2Q16
Aug-08-16 11:06AM  Why LYBs Olefins & Polyolefins Americas Revenue Fell in 2Q16
09:06AM  Reviewing LyondellBasells Valuations after Its 2Q16 Earnings
Aug-05-16 01:20PM  Why Did LyondellBasells 2Q16 Revenues Miss Analysts Estimates?
01:20PM  LyondellBasells 2Q16 Earnings Missed Analysts Estimates
Aug-04-16 03:03PM  ETFs with exposure to LyondellBasell Industries NV : August 4, 2016
01:04PM  LYONDELLBASELL INDUSTRIES N.V. Financials
Aug-03-16 11:34AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 11:07AM  Dow Chemicals 2Q16 Earnings Proved Analysts Estimates Wrong
Aug-01-16 12:51PM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : August 1, 2016
10:45AM  Five Stocks in Spotlight Amid Earnings, M&A News at Insider Monkey
09:16AM  Long-term bullish play in LyondellBasell
Jul-29-16 06:03PM  Edited Transcript of LYB earnings conference call or presentation 29-Jul-16 3:00pm GMT
02:12PM  LyondellBasell (LYB) Stock Falls on Q2 Earnings, Revenue Miss
12:09PM  LyondellBasell to Build High Density Polyethylene Plant on U.S. Gulf Coast PR Newswire
11:37AM  10 High-Yield Dividend Stocks With 20% Annual Returns to Buy Now
10:07AM  Trending Stocks: Xerox, LyondellBasell, Enbridge, and 2 More at Insider Monkey
09:27AM  LyondellBasell (LYB) Q2 Earnings & Sales Miss Estimates
08:35AM  [$$] LyondellBasell's Revenue Falls Across Its Segments at The Wall Street Journal
07:51AM  LyondellBasell (LYB) Misses Q2 Earnings & Sales Estimates
07:14AM  LyondellBasell misses Street 2Q forecasts
07:07AM  Q2 2016 LyondellBasell Industries NV Earnings Release - Before Market Open
07:02AM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
07:00AM  LyondellBasell Reports Second-Quarter 2016 Earnings PR Newswire
Jul-27-16 09:05AM  How Do LyondellBasells Valuations Compare to Peers?
08:55AM  Is LyondellBasell (LYB) Set to Disappoint in Q2 Earnings?
06:15AM  LyondellBasell to Address Jefferies Industrials Conference PR Newswire
Jul-26-16 11:34AM  Europe, China, and India Sales Rose, but Not Enough Not Help PPG Industries
11:05AM  What Do Analysts Recommend for LyondellBasell?
09:05AM  Why LyondellBasells Capital Expenditure Will Be High in 2Q16
Jul-25-16 12:04PM  Can LyondellBasell Continue to Raise Net Profit Margin in 2Q16?
04:12AM  Dividend Investors Should Research These 10 Stocks - July
Jul-24-16 10:45PM  Why Analysts Are Expecting Lower Revenue for LyondellBasell in 2Q16
Jul-22-16 07:55PM  Why Has the JPMorgan Large-Cap Growth Fund Done so Poorly in 2016?
09:00AM  LyondellBasell Board Authorizes Interim Dividend PR Newswire
Jul-21-16 08:11AM  LyondellBasell Industries NV breached its 50 day moving average in a Bullish Manner : LYB-US : July 21, 2016
Jul-19-16 04:50PM  [video]3 Prudent Stocks to Own in a Frothy Market
03:59PM  What Are Analysts Predicting for Dow Chemical Revenue in 2Q16?
03:51PM  Bahnsen: Enterprise Products is the cream of the crop nam...
Jul-15-16 08:15AM  LyondellBasell to Discuss Second-Quarter Results on Friday, July 29, 2016 PR Newswire
02:18AM  LyondellBasell Selects WorleyParsons for PO/TBA Plant Integrated Project Management Business Wire
Jul-12-16 11:40AM  Refinery M&A Heats Up
Jul-07-16 05:25PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
Jul-06-16 11:38AM  [$$] Tighter Supply for Now at The Wall Street Journal
Jul-05-16 09:25AM  LyondellBasell (LYB) Stock Price Target Cut at Jefferies
04:16AM  5 Companies for Enterprising Investors Near 52-Week Lows
Jun-28-16 06:01PM  After-hours buzz: Nike, United Technologies, LyondellBasell & more at CNBC
08:04AM  LyondellBasell to Gain from Expansion Moves Amid Challenges
Jun-27-16 01:20PM  10 Most Undervalued Companies for the Enterprising Investor
12:08PM  LyondellBasell (LYB) Stock Slips on RBC Capital Downgrade
07:56AM  Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan
06:17AM  LyondellBasell downgraded by RBC Capital Mkts
Jun-26-16 05:15PM  10 Companies for Enterprising Dividend Investors - June
Jun-13-16 03:27PM  LyondellBasell Charts Tell the True Tale
09:07AM  Heres Why These Five Stocks Are In the Spotlight at Insider Monkey
08:55AM  Top Analyst Upgrades and Downgrades: AMD, Agios Pharma, Baidu, Diamond Offshore, LyondellBasell, Occidental Petroleum and More at 24/7 Wall St.
Jun-11-16 12:01AM  This Weekend's Barron's: The Midyear Roundtable with Insights from Nine Market Experts ~ No Recession in Sight ~ Retailer Williams-Sonoma Is 'Amazon-Proof' at Barrons.com
12:01AM  [$$] LyondellBasell Offers a 4.2% Yield and Upside at Barrons.com
Jun-07-16 12:44PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-06-16 05:15PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct F
May-31-16 12:16PM  LyondellBasell to Address Deutsche Bank Global Industrials and Materials Summit PR Newswire
May-29-16 06:00PM  The Share Buyback Report: The Materials Sector (MON, LYB) at Investopedia
May-17-16 02:04PM  LyondellBasell to Address the Bernstein 32nd Annual Strategic Decisions Conference PR Newswire
May-16-16 04:03PM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
06:26AM  LyondellBasell Bumps Up Dividend, Announces Share Buyback
May-13-16 09:43AM  LyondellBasell (LYB) Stock Climbs on Stock Buyback, Dividend Hike at TheStreet
08:55AM  LyondellBasell Announces New Share Repurchase Program and Increased Dividend PR Newswire
May-09-16 05:43PM  LyondellBasell Receives National MS Society Circle of Distinction Award PR Newswire
May-06-16 08:16AM  Chemical Stocks Reporting Q1 Earnings on May 9: IFF, PAH Zacks
May-02-16 04:38PM  LyondellBasell to Address Goldman Sachs Basic Materials Conference PR Newswire
08:35AM  LyondellBasell Industries NV breached its 50 day moving average in a Bearish Manner : LYB-US : May 2, 2016 at Capital Cube
Apr-29-16 03:09PM  ETFs with exposure to LyondellBasell Industries NV : April 29, 2016 at Capital Cube
10:13AM  LyondellBasell to Address Wells Fargo Securities Industrial and Construction Conference PR Newswire
Apr-28-16 10:50AM  LyondellBasell Industries NV :LYB-US: Earnings Analysis: Q1, 2016 By the Numbers at Capital Cube
Apr-27-16 08:30AM  LyondellBasell Announces Planned Departure of Sergey Vasnetsov PR Newswire
Apr-26-16 07:30AM  Greater Chicago Plans for Nearly $3.8 Billion in Projects in Coming Year, an Industrial Info News Alert Marketwired
Apr-25-16 09:58AM  LyondellBasell (LYB) Stock Price Target Raised at Barclays at TheStreet
Apr-22-16 10:57PM  Edited Transcript of LYB earnings conference call or presentation 22-Apr-16 3:00pm GMT Thomson Reuters StreetEvents
11:04AM  LyondellBasell (LYB) Trumps Q1 Earnings, Revenues Miss Zacks
09:29AM  How Will LyondellBasell (LYB) Stock React to Mixed Q1 Results? at TheStreet
08:40AM  LyondellBasell (LYB) Tops Q1 Earnings Estimates, Sales Miss Zacks
08:13AM  LyondellBasell Industries Q1 Revenue Miss Estimations Benzinga
07:17AM  LyondellBasell beats 1Q profit forecasts AP
07:07AM  Q1 2016 LyondellBasell Industries NV Earnings Release - Before Market Open CCBN
07:01AM  LYONDELLBASELL INDUSTRIES N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement EDGAR Online
07:00AM  LyondellBasell Reports First-Quarter 2016 Earnings PR Newswire
LyondellBasell Industries N.V. operates as a manufacturer of chemicals and polymers, refiner of crude oil, producer of gasoline blending components, and developer and licensor of technologies for production of polymers. The company operates in five segments: Olefins and PolyolefinsAmericas; Olefins and PolyolefinsEurope, Asia, International; Intermediates and Derivatives; Refining; and Technology. It produces and markets olefins, including ethylene, propylene, and butadiene; polyolefins, which consist of high density polyethylene, low density polyethylene, linear low density polyethylene, and polypropylene (PP); specialty polyolefins comprising PP compounds, catalloy process resins, and polybutene-1 resins; and aromatics, which include benzene. The company also produces and markets propylene oxide (PO); PO co-products, such as styrene monomers and tertiary butyl alcohol; PO derivatives consisting of propylene glycol, propylene glycol ethers, and butanediol; acetyls, including methanol, acetic acid, and vinyl acetate monomers; and ethylene derivatives, such as ethylene oxide, ethylene glycol, ethylene glycol ethers, and ethanol. In addition, it refines gasoline and components, ultra low sulfur diesel, jet fuel, lube oils, and aromatics. Further, the company develops and licenses chemical, polyolefin, and other process technologies, as well as provides associated engineering and other services; and develops, manufactures, and sells polyolefin catalysts. LyondellBasell Industries N.V. was founded in 2005 and is headquartered in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Covezzi MassimoSVP Research & DevelopmentApr 26Sale89.147,551673,1119,702Apr 26 04:28 PM
Vasnetsov SergeySVP Strategic PlanningApr 26Sale89.893,127281,0764,733Apr 26 04:28 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 09Sale82.531,100,00090,786,41077,354Mar 10 04:38 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerMar 08Sale82.041,000,00082,042,77779,646Mar 10 04:38 PM
Wolf Jacquelyn HSVP, Human ResourcesNov 19Sale94.601,944183,9028,627Nov 20 11:45 AM
Wolf Jacquelyn HSVP, Human ResourcesNov 18Option Exercise58.9715,026886,14523,159Nov 20 11:45 AM
Wolf Jacquelyn HSVP, Human ResourcesNov 18Sale94.441,450136,93220,306Nov 20 11:45 AM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 30Sale92.402,270,000209,745,03180,642Oct 30 07:57 PM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 29Sale92.24880,00081,169,26482,903Oct 30 07:57 PM
Covezzi MassimoSVP Research & DevelopmentOct 28Sale90.913,000272,73514,266Oct 29 10:42 AM
AI INTERNATIONAL CHEMICALS S.A10% OwnerOct 28Sale92.34850,00078,487,72583,780Oct 30 07:57 PM
Vasnetsov SergeySVP Strategic PlanningOct 09Sale97.2936,5533,556,2522,140Oct 14 06:01 PM
Somma Lawrence CVice President and TreasurerSep 09Buy84.64141,1853,510Sep 11 05:03 PM
CARROLL MILTONDirectorSep 03Sale84.003,000252,0001,901Sep 03 04:12 PM
CARROLL MILTONDirectorAug 31Sale85.201,500127,8064,901Sep 02 05:17 PM
TMO Thermo Fisher Scientific, Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific, Inc.
IndexS&P 500 P/E30.24 EPS (ttm)5.01 Insider Own0.20% Shs Outstand393.67M Perf Week-1.30%
Market Cap59.58B Forward P/E16.83 EPS next Y8.99 Insider Trans-29.48% Shs Float393.66M Perf Month-4.75%
Income2.00B PEG2.89 EPS next Q1.98 Inst Own89.40% Short Float1.31% Perf Quarter0.20%
Sales17.61B P/S3.38 EPS this Y4.60% Inst Trans-0.22% Short Ratio3.86 Perf Half Y16.03%
Book/sh53.98 P/B2.80 EPS next Y10.34% ROA- Target Price172.06 Perf Year21.36%
Cash/sh- P/C- EPS next 5Y10.47% ROE- 52W Range116.73 - 160.68 Perf YTD6.92%
Dividend0.60 P/FCF- EPS past 5Y15.00% ROI7.00% 52W High-5.81% Beta1.00
Dividend %0.40% Quick Ratio0.80 Sales past 5Y10.30% Gross Margin45.60% 52W Low29.66% ATR1.86
Employees52000 Current Ratio1.10 Sales Q/Q6.20% Oper. Margin- RSI (14)41.36 Volatility1.27% 1.15%
OptionableYes Debt/Eq0.67 EPS Q/Q2.20% Profit Margin- Rel Volume1.02 Prev Close151.26
ShortableYes LT Debt/Eq0.55 EarningsJul 28 BMO Payout- Avg Volume1.33M Price151.35
Recom1.60 SMA20-2.92% SMA50-1.25% SMA2005.96% Volume1,355,500 Change0.06%
May-27-16Reiterated Mizuho Buy $166 → $170
May-19-16Reiterated Mizuho Buy $163 → $166
May-03-16Reiterated Mizuho Buy $160 → $163
Apr-29-16Downgrade Jefferies Buy → Hold
Apr-04-16Reiterated Mizuho Buy $150 → $160
Mar-02-16Reiterated Topeka Capital Markets Buy $145 → $155
Jan-11-16Reiterated Stifel Buy $150 → $158
Jan-07-16Initiated Deutsche Bank Buy $160
Oct-06-15Initiated Argus Buy $145
Jul-23-15Reiterated Mizuho Buy $150 → $160
May-21-15Reiterated Barclays Overweight $160 → $165
Mar-10-15Initiated UBS Buy $160
Jan-21-15Reiterated Robert W. Baird Outperform $142 → $144
Aug-12-14Initiated Stifel Buy $150
Jan-30-14Reiterated Mizuho Buy $130 → $140
Jan-30-14Reiterated ISI Group Buy $121.50 → $130
Jan-10-14Reiterated UBS Buy $107 → $127
Jan-06-14Reiterated ISI Group Buy $111 → $121.50
Sep-10-13Reiterated Mizuho Buy $100 → $110
Jul-25-13Reiterated UBS Buy $96 → $101
Aug-25-16 06:04PM  How the FEI Acquisition Will Benefit Thermo Fisher Scientific
04:26PM  Thermo Fisher Scientifics Key Growth Strategy
08:22AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : August 25, 2016
Aug-23-16 09:42AM  Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug-22-16 10:25AM  Edited Transcript of TMO earnings conference call or presentation 28-Jul-16 12:30pm GMT
Aug-19-16 01:19PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : August 19, 2016
Aug-18-16 06:00PM  Illumina Closes Slightly Up on Takeover Reports at Investopedia
04:52PM  Will Thermo Fisher Buy Illumina? Analyst Sees 'Close To A 0%' Chance
03:48PM  Illumina Shares Gain 2%, Cooling Speculation of a Thermo Fisher Buyout
12:51PM  Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation
12:26PM  Illumina Pops on Takeover -- One Chart Gives it Perspective
12:23PM  Illumina: Back in Bidness? at Bloomberg
12:07PM  Illumina: Takeover Speculation 'Makes No Sense' at Barrons.com
11:14AM  Illumina Gains on Report of $30 Billion Thermo Fisher Offer at Bloomberg
11:14AM  Illumina Gains on Report of $30 Billion Offer From Thermo Fisher
Aug-12-16 01:04PM  THERMO FISHER SCIENTIFIC INC. Financials
Aug-11-16 09:00AM  Columbus Circle Investors Boldest Q2 Moves at Insider Monkey
Aug-09-16 06:15AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an
Aug-05-16 06:16PM  Why Medical Devices ETF Is Among The Winners Of 2016
02:22PM  New Research Reports for Tesla, Exxon, JNJ & Others
12:07PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 10-Q, Quarterly Report
Aug-04-16 03:21PM  ETFs with exposure to Thermo Fisher Scientific, Inc. : August 4, 2016
Aug-03-16 09:30AM  Zacks.com featured highlights: CBS, Alliance Data Systems, Heartland Financial, Aetna and Thermo Fisher Scientific
Aug-02-16 04:51PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:43AM  Thermo Fisher Scientific, Inc. :TMO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016
08:19AM  5 GARP Stocks for Alluring Returns
Aug-01-16 02:09PM  Crude slides, markets concerned
09:09AM  Boston Scientifics Updated Guidance for 2016
09:08AM  C.R. Bards Buying Spree for Its Urology Segment Is Paying Off
08:00AM  Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016 Business Wire
Jul-29-16 04:20PM  Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination
Jul-28-16 03:31PM  Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
10:08AM  How GoPro, Suncor, and 3 Other Companies Performed During Their Latest Quarters at Insider Monkey
09:48AM  Thermo Fisher tops Street 2Q forecasts
09:22AM  Stocks to Watch: Facebook, GoPro, Raytheon, Thermo Fisher, Alexion at The Wall Street Journal
07:59AM  Thermo Fisher (TMO) Tops Q1 Earnings, Lowers '16 Sales View
07:34AM  [$$] Thermo Fisher Beats Expectations, Raises Outlook at The Wall Street Journal
07:31AM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q2 2016 Thermo Fisher Scientific Inc Earnings Release - Before Market Open
06:00AM  Thermo Fisher Scientific Reports Second Quarter 2016 Results Business Wire
Jul-27-16 08:03PM  FEI bids up Thermo Fisher in its $4B deal at bizjournals.com
09:36AM  Solid Sequencing Array Sales Help Illumina Inc. in Q2 at Motley Fool
Jul-25-16 01:32PM  Thermo Fisher Scientifics 2Q16 Revenues: Whats in Store?
01:32PM  Before Thermo Fishers 2Q16 Earnings: Analysts Are Mostly Buy
09:06AM  Abbott Laboratories Avoids a Sell Rating from Analysts
Jul-22-16 09:51AM  4 Medical Instrument Stocks to Bet on This Earnings Season
Jul-20-16 03:02PM  Thermo Fisher (TMO) Q2 Earnings: Surprise in Store?
Jul-15-16 01:01PM  Yum!, Pepsi Among 10 NYSE Stocks Hitting 52-Week Highs Thursday at Insider Monkey
09:00AM  London-Based Cryder Capital Loads Up On Top Picks; Sells Off BlackRock at Insider Monkey
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
10:06AM  How Harvard Bioscience deals with the pros and cons of its own name at bizjournals.com
Jul-13-16 06:02PM  MedTech Tailwinds at a Glance: Which Stocks to Buy?
11:04AM  Can Thermo Fishers PPI Business System Continue to Drive Growth in 2016?
10:29AM  What Analysts Recommend ahead of Johnson & Johnsons 2Q16 Results
09:04AM  What Are Thermo Fishers Major Growth Catalysts in 2016?
Jul-12-16 09:05PM  Can Thermo Fishers Capital Allocation Strategy Keep Enhancing Shareholder Value?
08:08PM  How Innovation Is Driving Thermo Fisher Scientifics Growth
08:06PM  How Are Thermo Fishers Commercial Capabilities Driving Its Share Gains?
05:08PM  How Does Varian Medical Systems Valuation Compare to Peers?
09:08AM  What Lies Ahead for Thermo Fishers Life Sciences Solutions Business?
Jul-11-16 05:17PM  What Will Hillary Clinton's Plan Do For Medical Hardware Stocks?
12:06PM  Inside Thermo Fisher Scientifics Emerging Markets Strategy
08:56AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : July 11, 2016
05:05AM  5 Stocks Hit 52-Week High Prices
Jul-08-16 11:29AM  Understanding Thermo Fisher Scientifics Valuation among Peers
11:29AM  Most Analysts Recommend a Buy for Thermo Fisher Scientific
11:15AM  New Cell Culture Plate Eliminates Edge Effect during Extended Incubation Business Wire
09:08AM  Understanding Thermo Fisher Scientifics Financial Model
Jul-07-16 04:30PM  Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $1.5 Billion of Share Repurchases Business Wire
09:00AM  Medical Device Consolidation Frenzy: Here's How to Play it
Jul-05-16 05:30PM  Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2016 Business Wire
04:09PM  Illumina Downgraded On Outlook For Cancer, Academic Research
12:08PM  How is Medtronics Economic Value Strategy Driving its Growth?
Jul-01-16 05:01PM  THERMO FISHER SCIENTIFIC INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi
Jun-28-16 09:05AM  Top money managers take temperature of health stocks: 'Genomics' firms to soar at CNBC
08:00AM  Hunting for health-care winners
Jun-27-16 09:39AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : June 27, 2016
09:36AM  U.S. Supreme Court to hear genetic-testing kit patent fight
Jun-20-16 08:17AM  Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Jun-17-16 12:25PM  Thermo Fisher Scientific, Inc. Value Analysis (NYSE:TMO) : June 17, 2016
Jun-16-16 03:55PM  Heres what FEI's CEO had to say to employees about the impending sale at bizjournals.com
Jun-15-16 08:39AM  Thermo Fisher Scientific, Inc. breached its 50 day moving average in a Bearish Manner : TMO-US : June 15, 2016
Jun-13-16 08:00AM  Thermo Fisher Scientific and West China Hospital Partner on Joint Research Platform for Precision Medicine Business Wire
Jun-09-16 09:18AM  Premarket Research Report Covering the Medical Laboratories and Research Industry
Jun-08-16 03:33PM  There's a new most-valuable public company in the Bay State until August at bizjournals.com
03:11PM  More Momentum Seen for Thermo Fisher at TheStreet
09:08AM  Thermo Fisher (TMO) Stock Price Target Upped at Keybanc
06:00AM  'Mad Money' Lightning Round: Buy, Buy, Buy Time Warner
Jun-07-16 12:30PM  5 Companies Achieve 5a-Week Highs
Jun-06-16 08:00AM  Thermo Fisher Scientific Strengthens Life Sciences Leadership with New Instruments Launched at ASMS 2016 Business Wire
May-31-16 03:09PM  FEI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FEI Company PR Newswire
01:30PM  Thermo Fisher Scientific Inc. -- Moody's affirms Thermo Fisher's ratings following FEI acquisition announcement; outlook positive at Moody's
10:48AM  Milberg LLP Announces Investigation of Purchase of FEI Company by Thermo Fisher Scientific Inc. PR Newswire
10:07AM  Wide Ranging Interview With Larry Robbins On The Future Of Hedge funds And More
08:58AM  Thermo Fisher to Buy FEI, Boost Electron Microscopy Platform
08:32AM  How to Invest in the Life Cycle of a Drug at Motley Fool
May-30-16 02:31PM  Five Capital Goods Stocks Hedge Funds Are Betting On at Insider Monkey
May-27-16 07:30PM  Week in Review: S&P 500 Closes Best Week Since March
05:40PM  Thermo Fisher Buys Microscope Tech Specialist FEI at Investopedia
05:23PM  Thermo Fisher Buying FEI, Expanding In White Hot Pharma Market
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. The company's Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. This segment serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The company's Laboratory Products and Services segment offers sample preparation, storage, and preservation equipment; controlled temperature technology products; centrifugation products and biological safety cabinets; water analysis instruments and laboratory equipment; laboratory consumables; chemicals; research and safety market channel services; and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChief Executive OfficerAug 15Sale155.9625,0003,899,031295,998Aug 17 04:54 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Aug 10Sale156.005,023783,58831,914Aug 11 04:46 PM
HARRIS C MARTINDirectorAug 05Sale157.3339061,3594,648Aug 08 04:53 PM
Loewald Thomas WSenior Vice PresidentJul 13Option Exercise73.248,025587,75152,194Jul 14 04:35 PM
Loewald Thomas WSenior Vice PresidentJul 13Sale155.008,0251,243,87544,169Jul 14 04:35 PM
CASPER MARC NChief Executive OfficerJul 05Option Exercise54.9720,0001,099,400340,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 05Sale147.6920,0002,953,804320,998Jul 07 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Option Exercise54.9730,0001,649,100350,998Jul 06 04:42 PM
CASPER MARC NChief Executive OfficerJul 01Sale148.8530,0004,465,638320,998Jul 06 04:42 PM
Shine Daniel PSenior Vice PresidentJun 15Option Exercise54.976,900379,29328,779Jun 16 05:00 PM
Shine Daniel PSenior Vice PresidentJun 15Sale148.316,9001,023,35621,879Jun 16 05:00 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Option Exercise54.9768,2003,748,954138,777Jun 14 04:47 PM
WILVER PETER MExec. VP & Chief Admin OfficerJun 10Sale152.3868,20010,392,63370,577Jun 14 04:47 PM
MANZI JIM PDirectorJun 03Sale153.001,137173,96138,733Jun 06 04:41 PM
Loewald Thomas WSenior Vice PresidentJun 02Option Exercise73.2415,0001,098,60059,169Jun 06 04:39 PM
Loewald Thomas WSenior Vice PresidentJun 02Sale152.8415,0002,292,60044,169Jun 06 04:39 PM
Williamson StephenSr. VP and CFOMay 25Option Exercise54.973,740205,58833,821May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Option Exercise54.978,660476,04038,741May 26 04:38 PM
Williamson StephenSr. VP and CFOMay 24Sale150.298,6601,301,48330,081May 26 04:38 PM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Option Exercise68.386,357434,69425,671May 17 11:39 AM
HORNSTRA PETER EVP & Chief Accounting OfficerMay 16Sale150.007,8111,171,65017,860May 17 11:39 AM
Shine Daniel PSenior Vice PresidentApr 26Option Exercise54.975,000274,85027,892Apr 27 04:09 PM
Shine Daniel PSenior Vice PresidentApr 26Sale146.006,013877,89821,879Apr 27 04:09 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Option Exercise73.2410,000732,40046,937Apr 07 04:28 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Apr 05Sale141.8610,0001,418,58036,937Apr 07 04:28 PM
Durbin Patrick MSenior Vice PresidentApr 04Option Exercise64.3911,250724,37944,348Apr 06 04:21 PM
Durbin Patrick MSenior Vice PresidentApr 04Sale142.1816,2502,310,42528,098Apr 06 04:21 PM
Williamson StephenSr. VP and CFOMar 22Option Exercise51.634,592237,07830,081Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Option Exercise51.7510,708554,09536,197Mar 23 04:36 PM
Williamson StephenSr. VP and CFOMar 21Sale139.5010,7081,493,76625,489Mar 23 04:36 PM
CASPER MARC NChief Executive OfficerMar 14Sale139.2830,0004,178,296320,998Mar 16 05:40 PM
Malus Alan JExecutive Vice PresidentMar 10Option Exercise126.3925,9253,276,78873,211Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 10Sale139.0525,9253,604,80947,286Mar 14 04:47 PM
Malus Alan JExecutive Vice PresidentMar 09Option Exercise73.2411,525844,09162,732Mar 11 04:07 PM
Malus Alan JExecutive Vice PresidentMar 09Sale138.5015,4462,139,29047,286Mar 11 04:07 PM
Loewald Thomas WSenior Vice PresidentMar 03Option Exercise49.493,625179,40147,794Mar 04 07:15 PM
SPERLING SCOTT MDirectorMar 03Option Exercise36.8720,000737,40085,790Mar 07 04:31 PM
SPERLING SCOTT MDirectorMar 03Sale137.905,350737,74580,440Mar 07 04:31 PM
Loewald Thomas WSenior Vice PresidentMar 03Sale137.283,625497,64044,169Mar 04 07:15 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Mar 01Sale135.002,951398,38536,937Mar 02 05:12 PM
Shine Daniel PSenior Vice PresidentFeb 29Sale130.2461479,96722,892Mar 02 04:50 PM
Shine Daniel PSenior Vice PresidentFeb 26Option Exercise54.975,000274,85030,089Mar 01 05:30 PM
Shine Daniel PSenior Vice PresidentFeb 26Sale131.006,180809,58023,909Mar 01 05:30 PM
Malus Alan JExecutive Vice PresidentFeb 01Option Exercise59.04103,4006,105,022149,221Feb 02 04:41 PM
Malus Alan JExecutive Vice PresidentFeb 01Sale130.24103,40013,467,21145,821Feb 02 04:41 PM
Loewald Thomas WSenior Vice PresidentDec 14Option Exercise54.977,013385,50544,451Dec 16 03:47 PM
Loewald Thomas WSenior Vice PresidentDec 14Sale134.1813,0131,746,08431,438Dec 16 03:47 PM
Parrett William GDirectorDec 11Buy134.161,000134,16014,636Dec 15 03:36 PM
Malus Alan JExecutive Vice PresidentDec 07Option Exercise49.4982,3004,073,027128,121Dec 08 05:07 PM
Malus Alan JExecutive Vice PresidentDec 07Sale135.4982,30011,150,96345,821Dec 08 05:07 PM
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.Nov 04Sale135.001,692228,42033,415Nov 05 04:26 PM
HARRIS C MARTINDirectorNov 03Sale134.3553171,3404,038Nov 04 05:53 PM
MANZI JIM PDirectorNov 02Sale133.493,050407,14538,870Nov 03 05:33 PM
CASPER MARC NChief Executive OfficerSep 17Sale130.0025,0003,250,000360,607Sep 18 04:36 PM
Malus Alan JExecutive Vice PresidentAug 28Sale127.554,557581,24545,821Sep 01 05:07 PM
CRM salesforce.com, inc. daily Stock Chart
CRM [NYSE]
salesforce.com, inc.
IndexS&P 500 P/E- EPS (ttm)-0.02 Insider Own0.10% Shs Outstand672.52M Perf Week4.23%
Market Cap53.91B Forward P/E60.82 EPS next Y1.32 Insider Trans-76.07% Shs Float639.36M Perf Month-1.64%
Income-12.80M PEG- EPS next Q0.22 Inst Own89.00% Short Float1.99% Perf Quarter-3.83%
Sales7.07B P/S7.62 EPS this Y83.00% Inst Trans1.14% Short Ratio3.37 Perf Half Y14.97%
Book/sh8.24 P/B9.73 EPS next Y38.59% ROA-0.10% Target Price96.70 Perf Year16.99%
Cash/sh3.02 P/C26.54 EPS next 5Y29.92% ROE-0.30% 52W Range52.60 - 84.48 Perf YTD2.24%
Dividend- P/FCF38.58 EPS past 5Y-21.10% ROI0.00% 52W High-5.11% Beta1.56
Dividend %- Quick Ratio0.70 Sales past 5Y32.10% Gross Margin75.00% 52W Low52.40% ATR1.30
Employees19000 Current Ratio0.70 Sales Q/Q26.80% Oper. Margin1.90% RSI (14)54.65 Volatility1.44% 1.42%
OptionableYes Debt/Eq0.37 EPS Q/Q816.10% Profit Margin-0.20% Rel Volume2.01 Prev Close77.82
ShortableYes LT Debt/Eq0.37 EarningsAug 31 AMC Payout- Avg Volume3.77M Price80.16
Recom1.70 SMA200.56% SMA50-0.15% SMA2005.49% Volume7,484,000 Change3.01%
Jun-15-16Initiated BMO Capital Markets Outperform $98
May-19-16Reiterated Wunderlich Buy $93 → $101
May-19-16Reiterated Wedbush Outperform $95 → $98
May-19-16Reiterated Stifel Buy $85 → $93
May-19-16Reiterated MKM Partners Buy $86 → $96
May-19-16Reiterated Mizuho Buy $90 → $100
May-19-16Reiterated Canaccord Genuity Buy $88 → $95
May-19-16Reiterated Barclays Overweight $88 → $89
May-17-16Reiterated Jefferies Hold $60 → $74
May-12-16Reiterated Barclays Overweight $72 → $88
Mar-04-16Initiated Macquarie Outperform
Feb-25-16Reiterated Wedbush Outperform $92 → $95
Feb-25-16Reiterated FBR Capital Outperform $88 → $82
Feb-25-16Reiterated Barclays Overweight $67 → $72
Feb-10-16Upgrade Credit Agricole Outperform → Buy
Feb-10-16Reiterated Barclays Overweight $90 → $67
Feb-09-16Upgrade Jefferies Underperform → Hold
Dec-18-15Upgrade Wedbush Neutral → Outperform
Nov-20-15Reiterated DA Davidson Neutral $75 → $87
Nov-19-15Reiterated Wunderlich Buy $85 → $93
Aug-25-16 10:44PM  Benzinga's M&A Chatter for Thursday August 25, 2016
09:35PM  Tesla Tops Forbes' 2016 List of Most Innovative Companies (TSLA, CRM) at Investopedia
07:04PM  Salesforce: Undisputed Customer Relationship Management Leader
05:04PM  Why Did Salesforce Acquire BeyondCore?
04:30PM  Salesforce Executives to Participate in Upcoming Investor Events PR Newswire
04:15PM  Salesforce Grants Equity Awards Under Its Inducement Equity Incentive Plan PR Newswire
03:06PM  What Can We Expect from Salesforces Fiscal 2Q17 Results? at Market Realist
01:48PM  Workday's Latest Earnings Are More Proof Oracle and SAP Should Be Worried at TheStreet
12:36PM  Tesla (TSLA), Salesforce Top Forbes List of Most Innovative Companies, Apple Left Off
11:50AM  Forbes' top innovators for 2016
11:14AM  Want to build an app that works with Salesforce? Lighter Capital now has a fund for that at bizjournals.com
10:15AM  How Salesforce.com Shares Could Rise 200% by 2020 at 24/7 Wall St.
09:30AM  Salesforce CEO Marc Benioff relies on the same Zen Buddhist concept that propelled Steve Jobs to success
08:55AM  Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More at 24/7 Wall St.
Aug-24-16 03:23PM  Salesforce.com (CRM) Stock Up, Launching AI 'Einstein' at TheStreet
01:59PM  'I dont think he ever sleeps': Marc Benioffs late-night messaging habit is legendary Business Insider
01:37PM  The CEO of the startup Salesforce bought for $390 million two years ago is suddenly leaving Business Insider
01:11PM  Salesforce's next big product will be called 'Einstein' Business Insider
04:15AM  Tesla, Salesforce.com among Forbes' most innovative companies
Aug-23-16 06:41PM  How Cloud Is Changing the World's Technology Companies
02:35PM  You Know SaaS, But What Is PaaS?
Aug-22-16 01:35PM  Oracle Versus Salesforce: Trip Chowdhry Says Salesforce's Woes Are 'Fixable'
10:11AM  Salesforce Makes Its Tenth Purchase In 12 Months With BeyondCore Deal
Aug-20-16 10:35AM  Salesforce.com Earnings: 'Lowered' Expectations, Deals Raise Questions
Aug-19-16 11:28PM  [$$] Salesforce.com: Where Ambition Has Its Price at The Wall Street Journal
04:29PM  [$$] Salesforce.com: Where Ambition Has Its Price at The Wall Street Journal
01:30PM  Salesforce is suddenly hiring fewer people after spending nearly $4 billion buying companies this year Business Insider
Aug-18-16 05:01PM  A Method to Salesforce's Acquisition Madness? Gurufocus
08:00AM  Salesforce Unveils Telehealth Solution for Salesforce Health Cloud, Enabling Two-Way Video to Drive Deeper Patient Engagement PR Newswire
Aug-16-16 04:31PM  Will Salesforce.com Buying Spree Slow Profit Margin Growth?
03:37PM  [$$] Salesforce Acquires Business-Intelligence Startup BeyondCore at The Wall Street Journal
02:45PM  Why Salesforce.com Bought BeyondCore at Investopedia
01:47PM  The Reveal Of Salesforce's Big Bid For LinkedIn Makes This Analyst Nervous
10:32AM  Salesforce (CRM) to Buy Data Analytics Startup BeyondCore
08:30AM  Salesforce Positioned in Gartner's Leaders Quadrant in the 2016 Magic Quadrant for Sales Force Automation for 10th Consecutive Year PR Newswire
08:18AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : August 16, 2016
Aug-15-16 08:01PM  Salesforce continues its startup buying spree in a push to make more 'intelligent' software Business Insider
07:55PM  Salesforce acquires business-intelligence firm BeyondCore at MarketWatch
04:47PM  Salesforce.com Downgraded After Weak Sales-Channel Checks
03:03PM  Jim Simons' Top New Holdings
12:00PM  Our Economic Models Are Seriously Out of Date
08:30AM  Salesforce Updates Timing of its Second Quarter Fiscal 2017 Financial Results Conference Call PR Newswire
08:00AM  Introducing Salesforce Inbox Calendar--The Intelligent Calendar Designed for Salespeople PR Newswire
Aug-12-16 06:07PM  Can NetSuite Take Oracle to $10 Billion in SaaS Revenues? Gurufocus
05:54PM  [$$] Forty U.S. Companies Sign on to EU Data Protection Agreement at The Wall Street Journal
11:05AM  What Enabled Symantec to Raise Guidance for Fiscal 2017?
Aug-11-16 04:52PM  Here's how to win a chance to give a 'Shark Tank' style pitch to Mark Cuban at Dreamforce Business Insider
12:02PM  Today's Top 5 Stock Picks: Underpriced Growth at Barrons.com
11:04AM  What Analysts Are Recommending for Salesforces Stock
09:05AM  Where Does Salesforce Stand in the Global Software Space?
Aug-10-16 07:39PM  3 Cloud Stocks That Could Make You Rich at Motley Fool
02:00PM  Stay Away From These Large-Cap Value Sinks
Aug-09-16 03:44PM  Cramer: Twilio, In a Word, Is Terrific
01:02PM  The Story Behind Salesforce's Interest in LinkedIn Gurufocus
11:08AM  How Salesforces Quip Buyout Is Fueling Competition in Cloud Space
11:08AM  Why Salesforce Is Acquiring Quip
10:02AM  Kostin: S&P 500 year-end target remains 2,100
Aug-08-16 04:34PM  Will Salesforce.com Turn 'Cannons' On Smaller Zendesk?
Aug-05-16 07:11AM  [$$] Force companies to reveal anyone who makes more than the CEO at Financial Times
Aug-04-16 02:48PM  ETFs with exposure to salesforce.com, inc. : August 4, 2016
01:27PM  [$$] Salesforce Buy Is Offensive and Defensive at Barrons.com
10:32AM  Earnings: How Might MSFT Purchase of LNKD Affect Membership?
Aug-03-16 12:40PM  Salesforce Boosts Cloud Capabilities with Acquisition of Quip at Investopedia
09:06AM  Industry Analysts Have Mixed Opinions about Oracle-NetSuite Deal
Aug-02-16 06:58PM  Salesforce CEO Marc Benioff: Oracle is 'scrambling' for growth with $9.3 billion NetSuite deal Business Insider
04:13PM  Zendesk Earnings On Tap, With Update On Social Media, Facebook
04:12PM  Salesforce.com To Buy Quip, Maker Of 'Living Documents'
02:14PM  Spot the Unicorn Software Companies of Tomorrow (MS, CRM) at Investopedia
01:55PM  Salesforce.com to Buy Cloud App Provider Quip at Investopedia
01:50PM  A Closer Look at Five Tech Stocks in Spotlight on Tuesday at Insider Monkey
01:07PM  Salesforce scoops up Quip for $582 million at Silicon Beat
12:46PM  Tuesday links: shorting bonds
10:44AM  salesforce.com, inc. breached its 50 day moving average in a Bearish Manner : CRM-US : August 2, 2016
10:40AM  Dun & Bradstreet (DNB) Beats on Q2 Earnings & Revenues
10:07AM  Term Sheet Tuesday, August 2 at Fortune
09:08AM  How NetSuite Will Improve Oracles Position in the Cloud Space
08:30AM  Salesforce.com strikes a deal with Quip for $582M
08:00AM  Verizon Makes a Telematics Acquisition; IBM Reportedly Mulls a Retail Acquisition
07:46AM  The Morning Ledger: A Quick CFO Exit Can Spell Trouble at The Wall Street Journal
Aug-01-16 09:49PM  Salesforce to Acquire Quip Inc for $750 million (CRM) at Investopedia
07:27PM  Salesforce CEO Marc Benioff says a tech world 'rising star' convinced him to pay $750 million for a small startup Business Insider
06:57PM  Salesforce just spent $750 million to thumb its nose at Microsoft Business Insider
06:55PM  Salesforce buys collaboration-software maker Quip for $582 million at MarketWatch
06:47PM  [$$] Salesforce.com to Buy Quip for $582 Million at The Wall Street Journal
06:27PM  Will Salesforce.com (CRM) Stock Gain on Quip Acquisition? at TheStreet
06:25PM  Salesforce snaps up Quip, SF-based productivity app, for $582 million at bizjournals.com
05:42PM  Stocks to beat the August swoon
05:35PM  Salesforce to buy document-editing startup Quip for about $582 million
05:33PM  Salesforce Just Acquired This Microsoft Word-Killer For $582 Million at Fortune
05:29PM  Salesforce to buy document-editing startup Quip for about $582 mln Reuters
05:25PM  Salesforce Acquires Ex-Facebook CTO's Collaboration Startup Quip For $582 Million at Forbes
05:17PM  Salesforce.com buys Quip for $582 million at CNBC
05:13PM  Salesforce Buys Word-Processing App Quip for $582 Million at Bloomberg
05:03PM  Salesforce is buying a startup founded by Facebook's former CTO for $750 million Business Insider
04:58PM  Veeva Helps The Medicine Go Down Faster for Drug Giants
04:42PM  SALESFORCE COM INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events
01:56PM  Software M&A: Sky's the Limit for Cloud Computing?
01:27PM  The man some say will become CEO of Oracle has some interesting rules for meetings Business Insider
09:08AM  Cloud Margins for This SAP Segment Are Significantly High at Market Realist
06:20AM  [$$] Microsoft has become richer through its culture shift at Financial Times
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. In addition, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChairman of the Board and CEOAug 25Option Exercise27.0612,500338,28135,383,000Aug 25 08:21 PM
Benioff MarcChairman of the Board and CEOAug 25Sale79.6212,500995,19535,370,500Aug 25 08:21 PM
Benioff MarcChairman of the Board and CEOAug 24Option Exercise27.0612,500338,28135,383,000Aug 25 08:21 PM
Benioff MarcChairman of the Board and CEOAug 24Sale78.1012,500976,24035,370,500Aug 25 08:21 PM
Benioff MarcChairman of the Board and CEOAug 23Option Exercise27.0612,500338,28135,383,000Aug 23 08:25 PM
Harris ParkerCo-FounderAug 23Option Exercise27.065,000135,31337,620Aug 23 09:11 PM
Benioff MarcChairman of the Board and CEOAug 23Sale78.0112,500975,14535,370,500Aug 23 08:25 PM
Harris ParkerCo-FounderAug 23Sale78.015,000390,04032,620Aug 23 09:11 PM
Benioff MarcChairman of the Board & CEOAug 22Option Exercise27.0612,500338,28135,383,000Aug 22 07:40 PM
Benioff MarcChairman of the Board & CEOAug 22Sale77.2612,500965,75335,370,500Aug 22 07:40 PM
Benioff MarcChairman of the Board & CEOAug 19Option Exercise27.0612,500338,28135,383,000Aug 22 07:40 PM
Benioff MarcChairman of the Board & CEOAug 19Sale77.2012,500965,02035,370,500Aug 22 07:40 PM
Benioff MarcChairman of the Board & CEOAug 18Option Exercise27.0612,500338,28135,383,000Aug 18 08:23 PM
Benioff MarcChairman of the Board & CEOAug 18Sale76.8112,500960,12635,370,500Aug 18 08:23 PM
Benioff MarcChairman of the Board & CEOAug 17Option Exercise27.0612,500338,28135,383,000Aug 17 08:21 PM
Benioff MarcChairman of the Board & CEOAug 17Sale76.3712,500954,63935,370,500Aug 17 08:21 PM
Harris ParkerCo-FounderAug 16Option Exercise27.065,000135,31337,620Aug 16 09:24 PM
Benioff MarcChairman of the Board & CEOAug 16Option Exercise27.0612,500338,28135,383,000Aug 16 09:20 PM
Roos John VictorDirectorAug 16Sale78.9215712,39016,763Aug 16 09:17 PM
Benioff MarcChairman of the Board & CEOAug 16Sale78.3212,500979,03935,370,500Aug 16 09:20 PM
Harris ParkerCo-FounderAug 16Sale78.335,000391,63132,620Aug 16 09:24 PM
Benioff MarcChairman of the Board & CEOAug 15Option Exercise27.0612,500338,28135,383,000Aug 15 07:48 PM
Conway CraigDirectorAug 15Sale79.3340031,7328,868Aug 15 07:40 PM
Benioff MarcChairman of the Board & CEOAug 15Sale79.0312,500987,90035,370,500Aug 15 07:48 PM
Benioff MarcChairman of the Board & CEOAug 12Option Exercise27.0612,500338,28135,383,000Aug 15 07:48 PM
Benioff MarcChairman of the Board & CEOAug 12Sale81.4112,5001,017,62635,370,500Aug 15 07:48 PM
Benioff MarcChairman of the Board & CEOAug 11Option Exercise27.0612,500338,28135,383,000Aug 11 08:12 PM
BLOCK KEITHPres., Vice Chairman and COOAug 11Option Exercise37.9510,000379,50010,000Aug 11 09:05 PM
Benioff MarcChairman of the Board & CEOAug 11Sale81.2012,5001,014,98535,370,500Aug 11 08:12 PM
BLOCK KEITHPres., Vice Chairman and COOAug 11Sale81.0010,000810,0000Aug 11 09:05 PM
Benioff MarcChairman of the Board & CEOAug 10Option Exercise27.0612,500338,28135,383,000Aug 10 08:47 PM
Benioff MarcChairman of the Board & CEOAug 10Sale80.3612,5001,004,48735,370,500Aug 10 08:47 PM
Harris ParkerCo-FounderAug 09Option Exercise27.065,000135,31337,620Aug 09 08:44 PM
BLOCK KEITHPres., Vice Chairman and COOAug 09Option Exercise37.9510,000379,50010,000Aug 09 08:51 PM
Benioff MarcChairman of the Board & CEOAug 09Option Exercise27.0612,500338,28135,383,000Aug 09 08:56 PM
Harris ParkerCo-FounderAug 09Sale81.315,000406,56232,620Aug 09 08:44 PM
BLOCK KEITHPres., Vice Chairman and COOAug 09Sale81.2110,000812,0930Aug 09 08:51 PM
Benioff MarcChairman of the Board & CEOAug 09Sale81.3212,5001,016,44035,370,500Aug 09 08:56 PM
Roos John VictorDirectorAug 09Sale81.1115512,57216,920Aug 09 09:00 PM
Benioff MarcChairman of the Board & CEOAug 08Option Exercise27.0612,500338,28135,383,000Aug 08 07:03 PM
Benioff MarcChairman of the Board & CEOAug 08Sale81.2612,5001,015,69135,370,500Aug 08 07:03 PM
Benioff MarcChairman of the Board & CEOAug 05Option Exercise27.0612,500338,28135,383,000Aug 05 08:04 PM
Benioff MarcChairman of the Board & CEOAug 05Sale81.0812,5001,013,51835,370,500Aug 05 08:04 PM
Benioff MarcChairman of the Board & CEOAug 04Option Exercise27.0612,500338,28135,383,000Aug 04 08:30 PM
BLOCK KEITHPres., Vice Chairman and COOAug 04Option Exercise37.9520,000759,00020,000Aug 04 06:59 PM
Benioff MarcChairman of the Board & CEOAug 04Sale80.6712,5001,008,39835,370,500Aug 04 08:30 PM
BLOCK KEITHPres., Vice Chairman and COOAug 04Sale81.0020,0001,620,0000Aug 04 06:59 PM
Benioff MarcChairman of the Board & CEOAug 03Option Exercise27.0612,500338,28135,383,000Aug 03 06:06 PM
Benioff MarcChairman of the Board & CEOAug 03Sale80.1512,5001,001,83435,370,500Aug 03 06:06 PM
Benioff MarcChairman of the Board & CEOAug 02Option Exercise27.0612,500338,28135,383,000Aug 02 07:28 PM
Harris ParkerCo-FounderAug 02Option Exercise27.065,000135,31337,620Aug 02 07:43 PM
Benioff MarcChairman of the Board & CEOAug 02Sale80.1912,5001,002,32235,370,500Aug 02 07:28 PM
Harris ParkerCo-FounderAug 02Sale80.195,000400,96132,620Aug 02 07:43 PM
Roos John VictorDirectorAug 02Sale80.7615512,51817,075Aug 02 07:48 PM
Benioff MarcChairman of the Board & CEOAug 01Option Exercise27.0612,500338,28135,383,000Aug 01 08:46 PM
Benioff MarcChairman of the Board & CEOAug 01Sale80.9612,5001,012,06135,370,500Aug 01 08:46 PM
Benioff MarcChairman of the Board & CEOJul 29Option Exercise27.0612,500338,28135,383,000Aug 01 08:46 PM
Benioff MarcChairman of the Board & CEOJul 29Sale81.6712,5001,020,85635,370,500Aug 01 08:46 PM
BLOCK KEITHPres., Vice Chairman and COOJul 28Option Exercise37.9510,000379,50010,000Aug 01 07:18 PM
Benioff MarcChairman of the Board & CEOJul 28Option Exercise27.0612,500338,28135,383,000Aug 01 08:46 PM
BLOCK KEITHPres., Vice Chairman and COOJul 28Sale82.1010,000820,9940Aug 01 07:18 PM
Benioff MarcChairman of the Board & CEOJul 28Sale82.3012,5001,028,74635,370,500Aug 01 08:46 PM
Benioff MarcChairman of the Board & CEOJul 27Option Exercise27.0612,500338,28135,383,000Jul 27 07:31 PM
Benioff MarcChairman of the Board & CEOJul 27Sale81.4612,5001,018,27535,370,500Jul 27 07:31 PM
Benioff MarcChairman of the Board & CEOJul 26Option Exercise27.0612,500338,28135,383,000Jul 26 08:19 PM
Harris ParkerCo-FounderJul 26Option Exercise27.065,000135,31337,620Jul 26 08:25 PM
BLOCK KEITHPres., Vice Chairman and COOJul 26Option Exercise37.9510,000379,50010,000Jul 26 08:27 PM
Hawkins Mark JChief Financial OfficerJul 26Option Exercise59.648,624514,33516,029Jul 26 08:32 PM
Benioff MarcChairman of the Board & CEOJul 26Sale81.7312,5001,021,57035,370,500Jul 26 08:19 PM
Roos John VictorDirectorJul 26Sale82.0015512,71017,230Jul 26 08:22 PM
Harris ParkerCo-FounderJul 26Sale81.735,000408,66232,620Jul 26 08:25 PM
BLOCK KEITHPres., Vice Chairman and COOJul 26Sale81.8010,000818,0090Jul 26 08:27 PM
Hawkins Mark JChief Financial OfficerJul 26Sale81.808,624705,4507,405Jul 26 08:32 PM
Benioff MarcChairman of the Board & CEOJul 25Option Exercise27.0612,500338,28135,383,000Jul 25 07:40 PM
Benioff MarcChairman of the Board & CEOJul 25Sale82.1712,5001,027,13835,370,500Jul 25 07:40 PM
Weaver Amy EEVP, General CounselJul 25Sale82.202,722223,74212,956Jul 25 07:45 PM
Robbins Cynthia G.EVP, Global Employee SuccessJul 25Sale82.202,176178,8625,199Jul 25 07:50 PM
Benioff MarcChairman of the Board & CEOJul 22Option Exercise27.0612,500338,28135,383,000Jul 22 05:35 PM
Weaver Amy EEVP, General CounselJul 22Option Exercise0.005,149015,678Jul 25 07:45 PM
Robbins Cynthia G.EVP, Global Employee SuccessJul 22Option Exercise0.005,14907,375Jul 25 07:50 PM
Benioff MarcChairman of the Board & CEOJul 22Sale82.2612,5001,028,30735,370,500Jul 22 05:35 PM
Benioff MarcChairman of the Board & CEOJul 21Option Exercise27.0612,500338,28135,383,000Jul 21 07:29 PM
BLOCK KEITHPres., Vice Chairman and COOJul 21Option Exercise37.9510,000379,50010,000Jul 21 07:34 PM
Benioff MarcChairman of the Board & CEOJul 21Sale82.0612,5001,025,72235,370,500Jul 21 07:29 PM
BLOCK KEITHPres., Vice Chairman and COOJul 21Sale82.6810,000826,8200Jul 21 07:34 PM
Benioff MarcChairman of the Board & CEOJul 20Option Exercise27.0612,500338,28135,383,000Jul 20 06:25 PM
Benioff MarcChairman of the Board & CEOJul 20Sale82.3012,5001,028,75135,370,500Jul 20 06:25 PM
Benioff MarcChairman of the Board & CEOJul 19Option Exercise27.0612,500338,28135,383,000Jul 19 08:41 PM
BLOCK KEITHPres., Vice Chairman and COOJul 19Option Exercise37.9510,000379,50010,000Jul 19 08:43 PM
Harris ParkerCo-FounderJul 19Option Exercise27.065,000135,31337,620Jul 19 08:49 PM
Roos John VictorDirectorJul 19Sale81.4015512,61717,385Jul 19 08:38 PM
Benioff MarcChairman of the Board & CEOJul 19Sale81.3912,5001,017,33435,370,500Jul 19 08:41 PM
BLOCK KEITHPres., Vice Chairman and COOJul 19Sale81.4710,000814,6780Jul 19 08:43 PM
Harris ParkerCo-FounderJul 19Sale81.395,000406,93932,620Jul 19 08:49 PM
Benioff MarcChairman of the Board & CEOJul 18Option Exercise27.0612,500338,28135,383,000Jul 18 07:59 PM
Benioff MarcChairman of the Board & CEOJul 18Sale81.7512,5001,021,86035,370,500Jul 18 07:59 PM
Benioff MarcChairman of the Board & CEOJul 15Option Exercise27.0612,500338,28135,383,000Jul 15 07:08 PM
Benioff MarcChairman of the Board & CEOJul 15Sale81.4112,5001,017,58035,370,500Jul 15 07:08 PM
Conway CraigDirectorJul 15Sale81.8640032,7449,268Jul 15 07:11 PM
BLOCK KEITHPres., Vice Chairman and COOJul 14Option Exercise37.9510,000379,50010,000Jul 14 07:23 PM
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-6.14 Insider Own0.10% Shs Outstand395.62M Perf Week-6.57%
Market Cap93.49B Forward P/E13.79 EPS next Y17.14 Insider Trans- Shs Float395.29M Perf Month-9.20%
Income-2422.60M PEG- EPS next Q3.64 Inst Own87.30% Short Float1.34% Perf Quarter1.70%
Sales15.37B P/S6.08 EPS this Y23.00% Inst Trans-2.74% Short Ratio1.67 Perf Half Y-20.72%
Book/sh181.28 P/B1.30 EPS next Y22.45% ROA3.20% Target Price299.06 Perf Year-22.77%
Cash/sh1.28 P/C184.54 EPS next 5Y13.49% ROE6.00% 52W Range195.50 - 322.68 Perf YTD-24.38%
Dividend- P/FCF21.20 EPS past 5Y-50.40% ROI-1.30% 52W High-26.77% Beta0.72
Dividend %- Quick Ratio0.90 Sales past 5Y33.40% Gross Margin78.70% 52W Low20.87% ATR5.33
Employees31200 Current Ratio1.00 Sales Q/Q-77.20% Oper. Margin-17.50% RSI (14)34.03 Volatility2.76% 1.95%
OptionableYes Debt/Eq0.56 EPS Q/Q78.20% Profit Margin28.20% Rel Volume1.97 Prev Close243.27
ShortableYes LT Debt/Eq0.52 EarningsAug 08 BMO Payout0.00% Avg Volume3.17M Price236.31
Recom1.90 SMA20-6.32% SMA50-3.13% SMA200-10.96% Volume6,109,400 Change-2.86%
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Apr-07-16Downgrade Susquehanna Positive → Neutral
Apr-06-16Downgrade Mizuho Buy → Neutral $330 → $250
Mar-31-16Reiterated Canaccord Genuity Buy $340 → $320
Feb-23-16Reiterated Mizuho Buy $354 → $330
Feb-23-16Reiterated Deutsche Bank Buy $308 → $339
Feb-19-16Initiated Wells Fargo Outperform
Nov-24-15Reiterated Mizuho Buy $340 → $354
Aug-25-16 07:04PM  Elliott Management Added Allergan in 2Q16
04:09PM  Markets Right Now: Health care pulls stocks lower again
02:33PM  Teva Pharmaceutical Industries Ltd -- Moody's: Teva's Loss of Two Copaxone Patents is Credit Negative at Moody's
01:32PM  Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out at Barrons.com
11:04AM  AstraZenecas Recent Product Developments
09:30AM  Allergan, Humana, Biogen: Billionaires Favorite Healthcare Stocks For Q3 at Insider Monkey
08:06AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016
Aug-24-16 05:11PM  Pfizer on buying spree with AstraZeneca antibiotics deal
12:00PM  Top 5 Shareholders of Allergan (AGN) at Investopedia
11:04AM  Performance of AstraZenecas RI&A Segment in 2Q16
10:43AM  David Einhorn Cashed Out of These 9 Stocks
10:27AM  Stocks edge lower as mining and materials companies slip
09:00AM  Apple, McDonalds, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2 at Insider Monkey
07:01AM  Pfizer Picks Up AstraZeneca's Antibiotics Business
Aug-23-16 07:41PM  3 Stocks Billionaires Are Buying at Motley Fool
09:20AM  Blog Coverage Valeant Pharma Appoints New CEO
08:58AM  Pfizer Has Had A Busy M&A Year...Or Has It?
Aug-22-16 06:32PM  13F Filings: Thumbs Up Or Thumbs Down For Gladiators? at Forbes
04:05PM  Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise
01:24PM  [$$] Pfizer makes $14bn bet on cancer drugmaker Medivation at Financial Times
12:48PM  Carl Icahn Buys Allergan
11:46AM  Pfizer spends $14B on Medivation in cancer fight
11:04AM  Teva Pharmaceutical: A Successful Bond Financing Program in 2016
10:05AM  Allergan Makes an Eye-Opening Acquisition at Motley Fool
09:06AM  How Did Bristol-Myers Squibbs Oncology Segment Perform in 2Q16?
07:20AM  [$$] Pfizer agrees $14bn takeover of Medivation at Financial Times
06:53AM  EU mergers and takeovers (Aug 22) Reuters
Aug-20-16 08:34AM  9 Stocks Smart Investors Put Their Money in Last Quarter
Aug-19-16 07:25PM  Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN) at Investopedia
04:40PM  Actavis recalls diabetes drugs made by Durham-based Patheon at bizjournals.com
04:25PM  Allergan Upgraded As New Product Launch Could Drive Botox Sales
10:54AM  Top stocks for hedge funds
10:33AM  Allergan (AGN) Stock Should Outperform, Analyst Tells CNBC
08:55AM  Top Analyst Upgrades and Downgrades: AK Steel, Allergan, ArcelorMittal, Symantec, Teck Resources, US Steel, Emerson, Hormel and More at 24/7 Wall St.
08:32AM  Allergan (AGN) Stock Rises, Mizuho Upgrades to 'Buy'
07:57AM  4 Stocks Carl Icahn Is Buying in 2016
07:56AM  Early movers: CXW, HIBB, DE, FL, EL, GPS, AMAT, ROST, VIAB, NKE & more at CNBC
07:41AM  These three stocks are working now: Pro
05:34AM  Allergan upgraded by Mizuho
Aug-18-16 05:35PM  Hedge Fund Confidence in Stocks Improves in Q2 (CHTR, MS) at Investopedia
08:00AM  Allergan to Present at 2016 Wells Fargo Healthcare Conference PR Newswire
Aug-17-16 05:29PM  Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter
05:10PM  Allergan Features Prominently in Q2 2016 (AGN, PFE) at Investopedia
04:21PM  [$$] Four Picks for a Specialty Pharma Comeback at Barrons.com
02:58PM  Big Changes At The Top of Passport Capitals Portfolio As Yahoo (YHOO) Takes Top Spot at Insider Monkey
12:03PM  Billionaire Money Managers Sold off This Stock in the 2nd Quarter at Motley Fool
11:04AM  What Do Analysts Estimate for Merck?
09:04AM  Is Valeants Xifaxan Resuming Growth?
Aug-16-16 02:00PM  For Value Investors, Arbiter Partners Knows How to Pick 'Em
01:13PM  13F 2Q Wrap: Big Bets on Allergan; Buffett Buys Apple; Soros Sells Gold at Barrons.com
10:54AM  Will Allergan (AGN) Stock Be Helped as Icahn Makes New Bet on Shares?
10:25AM  Icahn Bets Big on Allergan; Trims PayPal Stake at Barrons.com
10:01AM  Credit Suisse Presents Bull And Bear Cases For Allergan
09:54AM  Icahn makes new bet on Allergan in Q2 -filing
09:33AM  Activist Carl Icahn Takes Stakes in Allergan, Herc Holdings, Slashes PayPal Position at Insider Monkey
Aug-15-16 05:52PM  Allergan Sees Action on 13F Deadline Day
04:39PM  Icahn makes new bet on Allergan, cuts Hertz in Q2 - filing
04:32PM  Icahn adds Allergan position; trims Hertz, PayPal stakes at MarketWatch
04:25PM  Hedge funds made big changes at drug companies in 2nd qtr -filings
04:05PM  David Tepper Raises Bet on Allergan, Adds 2 New Positions in Latest Quarter
01:22PM  Why is Time (TIME) Stock Popping Today?
01:05PM  Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis at 24/7 Wall St.
11:29AM  Why Allergan is Fine Without Large M&A
11:00AM  Billionaire David Teppers Biggest Q2 Moves Involve Western Digital, Facebook & Others at Insider Monkey
09:42AM  Appaloosa's Tepper Boosts Allergan Stake; Exits Delta And Facebook at Barrons.com
09:13AM  Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug-13-16 01:04PM  ALLERGAN PLC Financials
Aug-12-16 05:44PM  Third Point Takes New Stakes in Facebook, Energy Firms at The Wall Street Journal
05:01PM  David Tepper Goes Big on Allergan, Shies From S&P at The Wall Street Journal
Aug-11-16 07:14PM  Five Healthcare Stocks Billionaires Are Bullish On at Insider Monkey
05:41PM  Healthcare Growth Stocks in the S&P 500: Part 2
12:27PM  ETFs with exposure to Allergan Plc : August 11, 2016
11:30AM  Allergan Bought Itself an Exciting Opportunity in ForSight
11:16AM  Glaucoma Treatment Maker a $95M "Stepping Stone" for Allergan
09:31AM  Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox
09:15AM  Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox Accesswire
08:16AM  Allergan agrees to buy private biotech ForSight VISION5 for $95 mln at MarketWatch
08:00AM  Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio of Innovative Eye Health Products PR Newswire
Aug-10-16 02:42PM  Dow going to 20,000?
12:04PM  Pfizers Business Segments and Their Performance
10:18AM  Allergan Plc :AGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 02:28PM  Allergan Narrowly Beats Earnings, Thanks to Sales Surge
12:08AM  [$$] Allergan Revenue Increases, Though Loss Widens at The Wall Street Journal
Aug-08-16 05:45PM  Allergan reports 2Q loss AAP
04:45PM  [$$] Allergan Selloff Makes for Great Buying Opportunity at Barrons.com
04:25PM  US STOCKS-Wall Street takes tiny step back from record highs
04:22PM  Allergan Stock Is 'Misunderstood'
04:09PM  Markets Right Now: Stocks closing lower on Wall Street
04:00PM  Allergan Earnings Top, But Stock Falls On Lowered Guidance
02:49PM  US STOCKS-Wall Street steps back from record highs
02:26PM  [$$] Allergan Revenue Increases, Though Loss Widens at The Wall Street Journal
02:10PM  These 7 Stocks Are Seeing Big Volume Today -- Here's How to Trade Them Now
01:45PM  Good, bad, & ugly: Murphy Oil, Allergan & more
01:36PM  Allergan's Buying Something, If Not Biogen at Bloomberg
01:18PM  [$$] Allergan setback prompts healthcare slide at Financial Times
01:11PM  US STOCKS-S&P 500 slips as health stocks weigh
12:35PM  Allergan Doesn't Need Large M&A: CEO
12:08PM  Allergan Stock Sinks on Mixed Quarterly Results at TheStreet
11:56AM  Jim Cramer: Allergan & Bristol-Myers Are Misunderstood at TheStreet
11:48AM  Allergan (AGN) Tops Q2 Earnings, Revises '16 Outlook
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, and medical aesthetics, as well as dermatology and plastic surgery. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. Allergan plc also distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
ADBE Adobe Systems Incorporated daily Stock Chart
ADBE [NASD]
Adobe Systems Incorporated
IndexS&P 500 P/E57.45 EPS (ttm)1.77 Insider Own0.10% Shs Outstand500.03M Perf Week1.01%
Market Cap50.85B Forward P/E26.68 EPS next Y3.81 Insider Trans-95.20% Shs Float495.84M Perf Month3.84%
Income895.60M PEG2.04 EPS next Q0.73 Inst Own89.40% Short Float0.87% Perf Quarter2.33%
Sales5.31B P/S9.58 EPS this Y135.20% Inst Trans-0.34% Short Ratio1.86 Perf Half Y17.42%
Book/sh14.50 P/B7.01 EPS next Y32.83% ROA7.60% Target Price112.46 Perf Year31.50%
Cash/sh8.64 P/C11.77 EPS next 5Y28.18% ROE12.70% 52W Range71.27 - 101.93 Perf YTD8.25%
Dividend- P/FCF32.03 EPS past 5Y-3.40% ROI7.40% 52W High-0.24% Beta1.24
Dividend %- Quick Ratio2.20 Sales past 5Y4.80% Gross Margin85.10% 52W Low42.68% ATR1.20
Employees13893 Current Ratio2.20 Sales Q/Q20.30% Oper. Margin22.40% RSI (14)66.65 Volatility0.88% 1.17%
OptionableYes Debt/Eq0.00 EPS Q/Q65.80% Profit Margin16.90% Rel Volume0.50 Prev Close101.14
ShortableYes LT Debt/Eq0.26 EarningsSep 20 AMC Payout0.00% Avg Volume2.31M Price101.69
Recom1.80 SMA202.29% SMA504.23% SMA2009.49% Volume1,170,600 Change0.54%
Jul-26-16Initiated Piper Jaffray Overweight $125
Jun-22-16Reiterated UBS Buy $114 → $122
Jun-22-16Reiterated Rosenblatt Buy $112 → $120
Apr-21-16Resumed Credit Suisse Neutral $85 → $105
Apr-12-16Reiterated FBR Capital Mkt Perform $100 → $115
Apr-04-16Reiterated Dougherty & Company Buy $116 → $122
Mar-31-16Initiated Canaccord Genuity Buy $110
Mar-18-16Reiterated Wunderlich Hold $94 → $99
Mar-18-16Reiterated UBS Buy $105 → $114
Mar-18-16Reiterated RBC Capital Mkts Outperform $101 → $104
Mar-18-16Reiterated Dougherty & Company Buy $114 → $116
Jan-14-16Initiated Dougherty & Company Buy $114
Dec-14-15Reiterated Argus Buy $95 → $110
Dec-11-15Reiterated Wunderlich Hold $90 → $94
Dec-11-15Reiterated RBC Capital Mkts Outperform $100 → $112
Dec-11-15Reiterated Pivotal Research Group Buy $95 → $104
Dec-11-15Reiterated KeyBanc Capital Mkts Overweight $90 → $110
Dec-11-15Reiterated JP Morgan Overweight $95 → $100
Dec-11-15Reiterated FBR Capital Mkt Perform $87 → $100
Dec-08-15Reiterated Deutsche Bank Buy $90 → $110
Aug-25-16 07:04PM  Salesforce: Undisputed Customer Relationship Management Leader
Aug-24-16 05:28PM  VPMCX,HCAIX: Top Mutual Fund Holders of Adobe Systems (ADBE) at Investopedia
08:36AM  Pitney Bowes Turns to Aria Systems for Prompt Billing
Aug-23-16 12:57PM  Baird Incrementally Positive On Tableau Software's Surprise CEO Announcement
12:30PM  Bull trend intact, latest S&P 500 breakout attempt underway at MarketWatch
07:49AM  The Morning Download: Microsoft to Infuse Office Software with AI at The Wall Street Journal
07:25AM  3 Reasons It's Not Too Late to Board the Adobe Systems Incorporated Train at Motley Fool
Aug-22-16 03:00PM  Shopify: 'One Of The Best Ways To Invest In E-Commerce Growth,' Says KeyBanc
07:46AM  These 5 Rocket Stocks Look Ready for Blastoff
Aug-20-16 12:25PM  Mobile Marketing Automation Moves at Forbes
Aug-18-16 11:19AM  5 Technology Stocks Still Worth Buying at Fresh Highs
Aug-17-16 07:15AM  Logitech Expands Gaming Mouse Lineup with Logitech G Pro
Aug-16-16 02:56PM  Money manager says its time to move away from this years hot stock sectors at MarketWatch
10:32AM  Salesforce (CRM) to Buy Data Analytics Startup BeyondCore
Aug-12-16 02:15PM  Itron (ITRI) Q1 Earnings and Revenues Surpass Estimates
08:43AM  Texas Instruments to Donate $5.4 M for STEM Advancements
Aug-11-16 09:00AM  Adobe Reports Falling Consumer Goods Prices for Six Consecutive Months Business Wire
Aug-10-16 08:45AM  Avid Technology (AVID) Worth a Look: Stock Gains 6.6%
Aug-09-16 04:21PM  Google just put the nail in Adobe Flash's coffin
08:53AM  Watts Water (WTS) Beats Q2 Earnings & Revenues, Shares Up
Aug-08-16 04:34PM  Will Salesforce.com Turn 'Cannons' On Smaller Zendesk?
04:08PM  Facebook, Microsoft, Alphabet Stocks Are In Buy Range
Aug-03-16 04:26PM  Shopify Stock Rises On Q2 Beat; Apple Pay Support Set
10:25AM  Adobe Systems, Inc. breached its 50 day moving average in a Bearish Manner : ADBE-US : August 3, 2016
08:40AM  Dun & Bradstreet Corp (DNB) Catches Eye: Stock Jumps 7.6%
Aug-02-16 04:28PM  Apple's iPad Pro Is Faring Well, But Can't Replace a PC for Most Users
09:30AM  This Transatlantic Startup Is Signing Big Brands for Design Software at Fortune
Aug-01-16 07:00AM  Heres What U.S. Companies With EU Employees and Customers Need To Do at Fortune
Jul-29-16 01:52PM  This Photo Editing Startup Is Profitable and Making Millions in Revenue at Fortune
08:05AM  Netgear (NTGR) in Focus: Stock Jumps 7.1% in Session
Jul-28-16 04:33PM  Don't delete your Flash player just yet at San Jose Mercury News
Jul-27-16 09:06AM  Citrix (CTXS) Q2 Earnings and Revenues Beat; View Raised
Jul-26-16 04:13PM  Adobe Systems 'In The Right Markets At The Right Time'
08:31AM  Why Adobe Systems (ADBE) Stock Might be a Great Pick
06:55AM  Coverage initiated on Adobe Systems by Piper Jaffray
Jul-25-16 04:10PM  Media Alert: Adobe Releases Diversity Pay Data for U.S. Workforce Business Wire
10:28AM  Adobe Systems, Inc. :ADBE-US: Earnings Analysis: Q2, 2016 By the Numbers : July 25, 2016
Jul-22-16 06:01PM  Here's How the Cloud is Helping Tech Stocks Win
08:45AM  Is Adobe Systems (ADBE) a Great Growth Stock?
08:24AM  Adobe Systems, Inc. breached its 50 day moving average in a Bearish Manner : ADBE-US : July 22, 2016
08:07AM  Massive Cluster of Insider Selling at Lennox International Inc. (LII) and 2 Other Well-Known Companies at Insider Monkey
Jul-21-16 04:44PM  Top-Rated Apple Supplier Leads 5 Stocks Poised To Break Out
03:11PM  [$$] Firefox Will Dump Adobe's Flash in August at The Wall Street Journal
01:19PM  These Top Stocks Could Soon Provide Buying Opportunities
01:18PM  Mozilla Joins Google and Facebook in Phasing Out Adobe Flash at Fortune
Jul-20-16 10:09AM  How These Artists Used Google Spreadsheet for Beauty Not Drudgery at Fortune
08:00AM  VMware (VMW) Catches Eye: Stock Adds 9% in Session
Jul-19-16 06:59PM  Intel's (INTC) Knights to Raid the Supercomputing Industry
11:52AM  ETFs with exposure to Adobe Systems, Inc. : July 19, 2016
Jul-15-16 04:32PM  Microsoft Wins Big in Cloud Privacy Protection Lawsuit
04:24PM  Facebook, Netflix, Smith & Wesson, Adobe Lead Week's Insider Trades
Jul-14-16 05:33PM  Intel's Open Source Alliance to Boost Security Solutions
11:49AM  Online prices actually point to deflation, not inflation at CNBC
09:12AM  Customers Happier With Second Amazon Prime Day at Motley Fool
07:00AM  Adobe Report Shows Continued Deflation in U.S. Economy Business Wire
Jul-13-16 09:00AM  A high-tech mecca rises to rival Silicon Valley at CNBC
08:59AM  Shutterstock Climbs On Google Ad Win at Barrons.com
08:45AM  SAP-APWorks Team Up to Accelerate Industrial 3D Printing
Jul-12-16 04:23PM  Shutterstock Jumps On Google Deal As Adobe Rivalry Grows
07:27AM  New Strong Buy Stocks for July 12th
Jul-11-16 06:46PM  Adobe to Offer Better Signature Security with Cloud Consortium
08:54AM  Add to Your Adobe Long Position at TheStreet
08:18AM  Adobe Systems, Inc. breached its 50 day moving average in a Bullish Manner : ADBE-US : July 11, 2016
Jul-10-16 12:00PM  CODING CAMPS! at San Jose Mercury News
12:00PM  Bay Area girls stream into summer coding camps at San Jose Mercury News
10:15AM  Huge Sheryl Sandberg Trade Highlights Furious Insider Selling: Facebook, Shake Shack, Adobe and More
Jul-09-16 08:04AM  A Close Look at Adobes Margins in Fiscal 2Q16
Jul-08-16 08:23AM  Adobe Trumpets Need for Digital Signature Standard at Fortune
05:22AM  The immense power of video advertising
05:22AM  The heritage and future of the Adobe brand
05:22AM  Online advertising: How not to alienate consumers
05:22AM  75% of Adobes marketing dollars go into digital
Jul-07-16 09:19AM  10 high-profile cyberhacks still impacting consumers today at CNBC
Jul-06-16 02:05PM  What Are Analyst Recommendations for Adobe Stock? at Market Realist
02:05PM  What Are Analysts Saying about Adobe Now? at Market Realist
01:04PM  ADOBE SYSTEMS INC Financials
Jul-05-16 10:06AM  Adobe and Peers Continue to Lure Investors with Share Buybacks
10:05AM  Why Is Adobes Interest in Mobile App Development Good News?
09:09AM  Adobe Systems Incorporated (ADBE) Registers Notable Cluster of Insider Selling, Plus Two Other Companies with Insider Selling at Insider Monkey
Jul-01-16 07:30AM  CACI shifting focus from services to 'solutions.' Here's what that means. at bizjournals.com
Jun-30-16 09:19AM  What's Wrong With Adobe Systems Incorporated Stock? Absolutely Nothing at Motley Fool
09:09AM  Research Report Initiated on Select Application Software Equities
09:09AM  Research Report Initiated on Select Application Software Equities Company Spotlight
Jun-29-16 04:08PM  ADOBE SYSTEMS INC Files SEC form 10-Q, Quarterly Report
10:06AM  Adobe Is the Leader in Gartners Magic Quadrant, Again
Jun-28-16 05:05PM  Adobe Digital Marketing Performance in Fiscal 2Q16
04:08PM  Top Stock Picks for the Week of June 27th
01:05PM  Why Adobe Stock Fell after Fiscal 2Q16 Results
11:07AM  Adobe Marketing Cloud Continued Upward Trajectory in Fiscal 2Q16
09:08AM  Adobe and Other Tech Players Want More Digital Marketing Space
12:01AM  Adobe Rallies Industry to Drive Open Standard for Cloud-Based Digital Signatures Business Wire
Jun-27-16 02:06PM  New Stock Research Reports for June 27, 2016
02:05PM  How Adobes Digital Media Segment Helped It Post Growth in 2Q16
11:09AM  Here's Why Patient Growth Investors Will Be Richly Rewarded By Adobe at TheStreet
09:00AM  This VC who sold his last startup to Adobe just raised a $70 million fund in 3 months
08:58AM  Why Adobe Systems (ADBE) Could Be an Impressive Growth Stock
Jun-26-16 03:02PM  Cloud Growth Helps Adobe in 2nd Quarter Gurufocus
Jun-24-16 06:21PM  Brexit Bears Down On U.S. Stocks; Tesla Skids Hard For The Week
05:17PM  Week In Review: Brexit Shocks World; Tesla Stuns Fans; JPMorgan, BofA Stressed
05:10PM  Brexit Spoils Software M&A Lift: Salesforce, Adobe, Workday Fall at Investor's Business Daily
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. Adobe Systems Incorporated has a strategic partnership with comScore, Inc. The company was founded in 1982 and is headquartered in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryAug 23Option Exercise0.0027,500064,123Aug 24 04:08 PM
GARRETT MARKEVP, CFO & Asst. SecretaryAug 16Option Exercise0.0056,250056,250Aug 17 04:31 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Option Exercise34.032,33579,46076,614Aug 11 04:05 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.0010,0001,000,00064,279Aug 11 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceAug 10Sale100.002,335233,50074,279Aug 11 04:05 PM
Lewnes AnnEVP, Chief Marketing OfficerJul 29Sale98.404,000393,60043,099Aug 01 04:09 PM
DALEY JAMES EDirectorJul 20Option Exercise33.235,000166,15033,086Jul 21 04:08 PM
WARNOCK JOHN ECo-Chairman of the BoardJul 20Sale98.512,000197,024579,115Jul 21 04:10 PM
DALEY JAMES EDirectorJul 20Sale98.505,000492,50028,086Jul 21 04:08 PM
BARNHOLT EDWARD WDirectorJul 11Option Exercise37.0925,000927,25058,124Jul 11 05:56 PM
BARNHOLT EDWARD WDirectorJul 11Sale97.2525,0002,431,13333,124Jul 11 05:56 PM
Rencher BradleyEVP & GM, Digital MarketingJul 01Sale95.4637,5623,585,62747,269Jul 01 05:38 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJul 01Sale95.6827125,9291,348Jul 01 04:13 PM
LAMKIN BRYANEVP & GM, Digital MediaJul 01Sale95.049,616913,90523,665Jul 01 04:10 PM
WARNOCK JOHN ECo-Chairman of the BoardJun 30Sale95.154,000380,605581,115Jul 01 04:09 PM
ROSENSWEIG DANIELDirectorJun 29Sale92.9819,3001,794,57419,268Jul 11 04:57 PM
Lewnes AnnEVP, Chief Marketing OfficerJun 24Sale92.394,000369,56046,828Jun 24 04:32 PM
Lewnes AnnEVP, Chief Marketing OfficerMay 27Sale99.404,000397,59650,828May 31 04:09 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryMay 10Sale95.099,466900,16736,409May 11 04:17 PM
Lewnes AnnEVP, Chief Marketing OfficerApr 29Sale92.894,000371,56054,828May 02 04:29 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Option Exercise0.003,4260581,129Apr 14 04:49 PM
CALDERONI FRANKDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:47 PM
BARNHOLT EDWARD WDirectorApr 12Option Exercise0.003,426033,124Apr 14 04:45 PM
Desmond LauraDirectorApr 12Option Exercise0.003,426021,051Apr 14 04:43 PM
BURGESS ROBERT KDirectorApr 12Option Exercise0.003,426038,124Apr 14 04:42 PM
Banse AmyDirectorApr 12Option Exercise0.003,426027,791Apr 14 04:36 PM
ROSENSWEIG DANIELDirectorApr 12Option Exercise0.003,426051,568Apr 14 04:34 PM
DALEY JAMES EDirectorApr 12Option Exercise0.003,426028,086Apr 14 04:32 PM
GESCHKE CHARLES MCo-Chairman of the BoardApr 12Option Exercise0.003,4260299,973Apr 14 04:27 PM
Barlow Kelly JDirectorApr 12Option Exercise0.003,42603,426Apr 13 06:23 PM
SEDGEWICK ROBERTDirectorApr 12Option Exercise0.003,426079,347Apr 13 05:22 PM
CANNON MICHAEL RDirectorApr 12Option Exercise0.003,426033,124Apr 13 05:20 PM
WARNOCK JOHN ECo-Chairman of the BoardApr 12Sale93.295,000466,458577,703Apr 12 05:32 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 09Option Exercise0.002,81702,817Apr 12 05:34 PM
DALEY JAMES EDirectorApr 01Option Exercise33.825,000169,10029,660Apr 01 07:35 PM
NARAYEN SHANTANUPresident and CEOApr 01Option Exercise34.0322,422763,021321,394Apr 01 07:31 PM
NARAYEN SHANTANUPresident and CEOApr 01Sale94.8522,4222,126,678298,972Apr 01 07:31 PM
ROWLEY RICHARDVP, Corp. Controller & CAOApr 01Sale95.058,780834,5500Apr 01 07:28 PM
DALEY JAMES EDirectorApr 01Sale95.005,000475,00024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 31Sale93.992,767,739260,127,4666,000Mar 31 05:43 PM
DALEY JAMES EDirectorMar 30Option Exercise33.822,84096,04927,500Apr 01 07:35 PM
DALEY JAMES EDirectorMar 30Sale94.002,840266,96024,660Apr 01 07:35 PM
ValueAct Holdings, L.P.DirectorMar 30Sale93.764,000,000375,040,0002,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 29Sale92.971,965,580182,739,9736,773,739Mar 31 05:43 PM
ValueAct Holdings, L.P.DirectorMar 28Sale92.53100,0009,253,0008,739,319Mar 28 05:06 PM
ValueAct Holdings, L.P.DirectorMar 24Sale92.51821,80876,025,4588,839,319Mar 28 05:06 PM
ROWLEY RICHARDVP, Corp. Controller & CAOMar 24Sale92.464,146383,3498,780Mar 25 05:06 PM
Morris DonnaEVP, Cust. & Emp. ExperienceMar 22Sale93.0025,0002,325,00074,008Mar 23 04:38 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Option Exercise42.6125,0001,065,250321,547Mar 23 04:33 PM
WARNOCK JOHN ECo-Chairman of the BoardMar 21Sale92.709,000834,309587,703Mar 23 04:35 PM
GESCHKE CHARLES MCo-Chairman of the BoardMar 21Sale92.4825,0002,311,875296,547Mar 23 04:33 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 26Sale86.314,000345,23362,828Feb 29 06:02 PM
Lewnes AnnEVP, Chief Marketing OfficerFeb 03Option Exercise34.032,28077,58866,828Feb 05 04:14 PM
NARAYEN SHANTANUPresident and CEOFeb 01Option Exercise34.0322,422763,021321,394Feb 02 04:35 PM
NARAYEN SHANTANUPresident and CEOFeb 01Sale88.8022,4221,991,007298,972Feb 02 04:35 PM
ValueAct Holdings, L.P.DirectorJan 29Sale89.01185,00016,466,85011,773,739Feb 02 04:31 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 29Sale86.234,000344,90264,548Feb 01 04:37 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 29Sale86.2510,310889,28045,875Feb 01 04:31 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 26Sale86.8473,0006,338,99951,718Jan 27 04:34 PM
ValueAct Holdings, L.P.DirectorJan 25Sale89.005,000445,00011,958,739Jan 25 06:25 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 25Sale88.5253,3954,726,7490Jan 27 04:43 PM
GARRETT MARKEVP, CFO & Asst. SecretaryJan 24Option Exercise0.00108,359078,348Jan 27 04:43 PM
Morris DonnaEVP, Cust. & Emp. ExperienceJan 24Option Exercise0.0076,4750121,109Jan 27 04:41 PM
LAMKIN BRYANEVP & GM, Digital MediaJan 24Option Exercise0.0017,184027,464Jan 27 04:39 PM
Rencher BradleyEVP & GM, Digital MarketingJan 24Option Exercise0.00108,2000112,252Jan 27 04:36 PM
THOMPSON MATTHEWEVP WW Field OperationsJan 24Option Exercise0.00149,3590169,665Jan 27 04:34 PM
ROWLEY RICHARDVP, Corp. Controller & CAOJan 24Option Exercise0.0020,930017,893Jan 27 04:32 PM
DILLON MICHAEL AEVP, Gen. Counsel & SecretaryJan 24Option Exercise0.0061,567074,673Jan 27 04:45 PM
Lewnes AnnEVP, Chief Marketing OfficerJan 24Option Exercise0.0076,475090,649Jan 27 04:28 PM
ValueAct Holdings, L.P.DirectorJan 22Sale89.271,612,000143,903,24011,963,739Jan 25 06:25 PM
ValueAct Holdings, L.P.DirectorJan 21Sale89.56435,00038,958,60013,575,739Jan 25 06:25 PM
NARAYEN SHANTANUPresident and CEOJan 04Option Exercise34.0322,422763,021299,025Jan 05 04:33 PM
NARAYEN SHANTANUPresident and CEOJan 04Sale91.2422,4222,045,843276,603Jan 05 04:33 PM
NARAYEN SHANTANUPresident and CEODec 01Option Exercise34.0322,422763,021299,025Dec 02 04:16 PM
NARAYEN SHANTANUPresident and CEODec 01Sale91.8922,4222,060,308276,603Dec 02 04:16 PM
NARAYEN SHANTANUPresident and CEONov 02Option Exercise34.0322,422763,021299,025Nov 03 04:35 PM
NARAYEN SHANTANUPresident and CEONov 02Sale88.8522,4221,992,134276,603Nov 03 04:35 PM
DILLON MICHAEL ASVP, Gen. Counsel & SecretaryOct 29Sale88.125,000440,60825,173Oct 30 04:41 PM
Morris DonnaSVP, People and PlacesOct 26Sale88.0516,0001,408,80260,865Oct 27 04:31 PM
SEDGEWICK ROBERTDirectorOct 23Option Exercise23.2815,942371,13091,863Oct 23 07:06 PM
SEDGEWICK ROBERTDirectorOct 23Sale88.9815,9421,418,44375,921Oct 23 07:06 PM
DALEY JAMES EDirectorOct 22Option Exercise33.825,000169,10029,660Oct 23 07:08 PM
Rencher BradleySVP & GM, Digital MarketingOct 22Option Exercise34.1510,000341,47051,503Oct 23 07:11 PM
DALEY JAMES EDirectorOct 22Sale88.345,000441,67724,660Oct 23 07:08 PM
Rencher BradleySVP & GM, Digital MarketingOct 22Sale88.6626,0002,305,14225,503Oct 23 07:11 PM
DALEY JAMES EDirectorOct 15Option Exercise33.825,000169,10029,660Oct 16 06:16 PM
DALEY JAMES EDirectorOct 15Sale86.005,000430,00024,660Oct 16 06:16 PM
Lewnes AnnSVP, Chief Marketing OfficerOct 14Sale84.004,000336,00030,405Oct 15 04:15 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 13Sale84.004,699394,724296,547Oct 13 06:20 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 12Option Exercise28.8556,8871,641,079332,947Oct 13 06:20 PM
GESCHKE CHARLES MCo-Chairman of the BoardOct 12Sale84.1631,7012,667,988301,246Oct 13 06:20 PM
NARAYEN SHANTANUPresident and CEOOct 01Option Exercise34.0322,422763,021299,025Oct 02 04:46 PM
NARAYEN SHANTANUPresident and CEOOct 01Sale82.1222,4221,841,342276,603Oct 02 04:46 PM
Lewnes AnnSVP, Chief Marketing OfficerSep 09Sale80.794,000323,16034,405Sep 10 04:46 PM
NARAYEN SHANTANUPresident and CEOSep 01Option Exercise34.0322,422763,021299,025Sep 02 06:27 PM
NARAYEN SHANTANUPresident and CEOSep 01Sale76.6022,4221,717,577276,603Sep 02 06:27 PM
SHPG Shire plc daily Stock Chart
SHPG [NASD]
Shire plc
Index- P/E30.44 EPS (ttm)6.30 Insider Own0.10% Shs Outstand295.47M Perf Week-3.49%
Market Cap56.63B Forward P/E12.59 EPS next Y15.23 Insider Trans0.00% Shs Float181.49M Perf Month-1.42%
Income1.26B PEG2.13 EPS next Q3.19 Inst Own24.50% Short Float0.74% Perf Quarter0.75%
Sales7.51B P/S7.54 EPS this Y-59.40% Inst Trans28.02% Short Ratio0.60 Perf Half Y19.55%
Book/sh130.77 P/B1.47 EPS next Y17.76% ROA3.10% Target Price252.54 Perf Year-13.95%
Cash/sh2.35 P/C81.67 EPS next 5Y14.30% ROE6.70% 52W Range146.98 - 236.63 Perf YTD-6.11%
Dividend0.80 P/FCF- EPS past 5Y16.50% ROI12.00% 52W High-19.00% Beta1.10
Dividend %0.42% Quick Ratio0.60 Sales past 5Y13.10% Gross Margin79.50% 52W Low30.40% ATR3.28
Employees5548 Current Ratio1.40 Sales Q/Q56.00% Oper. Margin19.30% RSI (14)45.76 Volatility1.92% 1.41%
OptionableYes Debt/Eq0.81 EPS Q/Q-54.20% Profit Margin13.20% Rel Volume0.38 Prev Close193.85
ShortableYes LT Debt/Eq0.72 EarningsAug 02 BMO Payout20.20% Avg Volume2.22M Price191.67
Recom1.70 SMA20-3.21% SMA501.01% SMA2004.45% Volume871,500 Change-1.12%
Jun-03-16Reiterated Jefferies Buy $223 → $262
May-26-16Initiated Stifel Buy $230
May-06-16Initiated Liberum Buy
Feb-26-16Initiated Cantor Fitzgerald Buy
Feb-10-16Upgrade RBC Capital Mkts Sector Perform → Outperform $240 → $240
Feb-10-16Initiated Guggenheim Neutral
Jan-15-16Upgrade BofA/Merrill Neutral → Buy
Jan-12-16Upgrade Credit Suisse Neutral → Outperform
Jan-12-16Reiterated RBC Capital Mkts Sector Perform $248 → $240
Nov-17-15Upgrade Leerink Partners Mkt Perform → Outperform $239
Nov-03-15Upgrade HSBC Securities Hold → Buy
Oct-26-15Reiterated RBC Capital Mkts Sector Perform $263 → $248
Oct-14-15Initiated Northland Capital Outperform $288
Sep-30-15Upgrade HSBC Securities Reduce → Hold
Aug-06-15Downgrade Exane BNP Paribas Outperform → Neutral
Jul-16-15Resumed Berenberg Buy
Apr-29-15Initiated Exane BNP Paribas Outperform
Jan-26-15Reiterated RBC Capital Mkts Sector Perform $238 → $248
Jan-12-15Reiterated RBC Capital Mkts Sector Perform $221 → $238
Oct-15-14Upgrade CRT Capital Fair Value → Buy $225
Aug-26-16 12:48AM  Stocks Sag Ahead of Fed Summit at The Wall Street Journal
Aug-25-16 12:04PM  Why Roche Might Be Interested in BioMarin
09:30AM  Allergan, Humana, Biogen: Billionaires Favorite Healthcare Stocks For Q3 at Insider Monkey
09:19AM  Stocks Fall as Investors Look to Fed's Jackson Hole Meeting at The Wall Street Journal
07:00AM  Shire and Jennifer Aniston Want to Inspire People to Show Their Eyes Some Love and Help Raise Awareness of Chronic Dry Eye PR Newswire
Aug-23-16 02:29PM  Tiger Management Welcomes Microsoft, Pandora to Portfolio, Chases Off Netflix, Teva at Insider Monkey
Aug-22-16 02:47PM  Stocks Struggle for Direction as Jackson Hole Conference Looms
11:36AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
10:00AM  Most Important Mergers and Acquisitions of 2016 (SHPG, ABT) at Investopedia
Aug-20-16 08:34AM  9 Stocks Smart Investors Put Their Money in Last Quarter
Aug-17-16 05:29PM  Steve Mandel Buys Shire, Axes 6 Positions in 2nd Quarter
Aug-15-16 05:44PM  Leon Cooperman's Omega Buys Netflix, Citigroup, Shire
08:46AM  Billionaire Dan Loeb Adds Facebook, Monsanto to Third Points Portfolio in Q2 at Insider Monkey
Aug-13-16 07:50AM  Heres what we know about Shires cost-cutting plans for the next three years at bizjournals.com
Aug-12-16 06:11PM  Martin Whitman's Third Avenue Management Purchases 8 Stocks
01:59PM  John Keeley Gains 3 in 2nd Quarter
01:04PM  SHIRE PLC Financials
Aug-11-16 06:08AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Aug-10-16 06:00AM  Radius Health, Subject of Takeover Talk, Rises Again
Aug-09-16 07:00AM  VONVENDI, The First and Only Recombinant Treatment for Adults Affected by Von Willebrand Disease, Launches in the U.S. PR Newswire
Aug-08-16 05:46PM  How Did Regeneron Perform in 2Q16?
03:15PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:05AM  What Are Analysts Recommending for Shire?
Aug-05-16 06:47PM  Elliott Associates sues AbbVie over failed bid for Shire
05:59PM  [$$] Elliott Sues AbbVie Over Failed Inversion Deal With Shire at The Wall Street Journal
05:02PM  SHIRE PLC Files SEC form 10-Q, Quarterly Report
01:59PM  ETFs with exposure to Shire Plc : August 5, 2016
11:07AM  An Update on Shires Upcoming Milestones
09:06AM  2Q16 Results of Shires Baxalta Acquisition
09:05AM  Can Valeants Margins for 2Q16 Meet Expectations?
Aug-04-16 04:48PM  How Did Shires Franchises Perform in 2Q16?
04:48PM  Whats behind Shires 2Q16 Earnings Surprise?
10:21AM  Shire Plc :SHPG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016
Aug-03-16 12:34PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
09:04AM  Update on Analyst Recommendations for Alexion
Aug-02-16 04:16PM  3 More Drugmakers Beat Q2 Earnings Estimates, But Guidance Mixed
10:32AM  Not Dead Yet: Shire, Mallinckrodt Beat Estimates, Kicking Off Specialty Rx Earnings Season at Barrons.com
09:59AM  [$$] Shire Posts Second-Quarter Loss, but Shares Climb on Post-Merger Numbers at The Wall Street Journal
08:16AM  Shire's Share Surge on Strong Second-Quarter Results
07:55AM  Shire reports 2Q loss
07:18AM  SHIRE PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:08AM  Shire Says Baxalta Combination to Boost Profit and Sales at Bloomberg
07:00AM  Shire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook PR Newswire
Aug-01-16 02:28PM  What to Expect When Shire (SHPG) Reports Q2 Earnings Tomorrow
02:05PM  [$$] Shire Earnings: What to Watch at The Wall Street Journal
08:42AM  Should You Buy Shire plc (SHPG) Ahead of Earnings?
07:00AM  Shire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System PR Newswire
06:04AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jul-31-16 11:14AM  BioMarin: Why So Many Buy Recommendations?
Jul-29-16 04:20PM  Shire Recommends ADS Holders Reject TRC Capital's Mini-Tender Offer PR Newswire
01:20PM  Vertexs Cystic Fibrosis Drugs Drove Revenue Growth in 2Q16
07:00AM  Shire's SHP626 (Volixibat) Receives FDA Fast Track Designation for an Investigational Treatment for Adults Who Have Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis PR Newswire
Jul-28-16 09:07AM  What to Expect from Shires Genetic Disease Franchise
Jul-27-16 11:09AM  How Will Major Drugs in GI Franchise Perform in 2Q16?
09:12AM  How Will Shires ADHD Franchise Perform in 2Q16?
Jul-26-16 05:17PM  How Much Revenue Growth Will Shire Record in 2Q16?
05:17PM  What Do Analysts Recommend for Shire?
02:39PM  How Analysts Rate Mallinckrodt Compared to Its Peers
08:35AM  Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016 at 24/7 Wall St.
07:00AM  ADYNOVATE Phase 3 Efficacy and Safety Data in Children to be Showcased During International Congress of the World Federation of Hemophilia PR Newswire
Jul-25-16 10:34AM  Specialty Pharma: Earnings Better Be Goodor Else at Barrons.com
02:01AM  Merrimack Announces ONIVYDE® Regimen Receives Positive CHMP Opinion in European Union PR Newswire
02:00AM  ONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Progressed Following Gemcitabine Based Therapy PR Newswire
Jul-22-16 01:07PM  Inside Lillys 2Q16 Estimates for Its Neuroscience Franchise
Jul-21-16 04:41PM  How Analysts Think Investors Should Play Vertex Pharmaceuticals
10:39AM  Valeant & Endo: Imagining a World With No Drug Pricing Controversies at Barrons.com
07:00AM  Shire Launches Pediatric Indication for Immunodeficiency Treatment HyQvia in Europe PR Newswire
Jul-20-16 01:21PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jul-19-16 07:00AM  Shire Reinforces Commitment in Hematology with Robust Data Presented at International Congress of the World Federation of Hemophilia PR Newswire
Jul-14-16 03:10PM  Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
08:56AM  Coverage Initiated on Select Healthcare Stocks
Jul-13-16 10:10AM  Company News for July 13, 2016
09:05AM  Regenerons Dupilumab: How Much Potential Does It Hold?
Jul-12-16 08:44PM  Multimedia assets now available: FDA Approves Shire's Xiidra (lifitegrast ophthalmic solution) 5% - The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease PR Newswire
08:20PM  Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
05:24PM  Shire shares up after US approves dry-eye disease treatment at CNBC
04:04PM  Shire Stock Up As Eye Drug Wins Early Approval, Broad Label
12:29PM  Five Stocks That Have Investors Excited Today at Insider Monkey
11:10AM  Shire Gains Key FDA Approval in Dry Eye Treatment
10:31AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
09:34AM  [$$] Shire boosted by FDA approval of dry eye drug at Financial Times
05:29AM  Shires Shares Rise on FDA Approval of Dry Eye Med
03:55AM  Shire Surges After FDA Approves Xiidra for Dry-Eye Disease
Jul-11-16 09:34PM  FDA approves Shire's keenly-watched eye drug Reuters
08:20PM  FDA Approves Shire's Dry-Eye Treatment at The Wall Street Journal
07:08PM  Regulatory Approval - FDA Approves Shires Xiidra (lifitegrast ophthalmic solution) 5% The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease PR Newswire
11:36AM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jul-08-16 06:36PM  Shire (SHPG) Gets EU Nod for Label Expansion of Revestive
Jul-07-16 02:00AM  Shire Receives Extension of Market Authorization in Europe for Revestive (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS) PR Newswire
Jul-06-16 02:06PM  Understanding the Valuation Catalysts for BioMarin in 4Q16
Jul-05-16 12:12PM  5 Best Bets for the Q2 Earnings Season
Jul-01-16 04:52PM  10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
04:30PM  Shire Stock Up Despite Mixed Data on Pipeline Candidate
12:19PM  SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits
Jun-30-16 04:44PM  Shire Stock Up As Premature Infant Treatment Yields Mixed Results
03:01PM  How Is Horizon Pharma Looking on a Price-to-Sales Basis?
01:25PM  SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
12:06PM  Why ConAgra Foods, Hertz Global, Shire PLC and Two Other Stocks Are on the Move Today at Insider Monkey
09:57AM  Shire stock up 1.3% after premature infant treatment meets secondary endpoints in midstage trial at MarketWatch
07:00AM  Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants PR Newswire
Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), including VYVANSE/VENVANSE, a pro-drug stimulant; ELVANSE/TYVENSE; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist for oral symptomatic treatment of chronic constipation in women. In addition, it offers FOSRENOL, a phosphate binder for use in end-stage renal disease receiving dialysis; and XAGRID for the reduction of elevated platelet counts in at-risk essential thrombocythemia patients, as well as for the treatment of thrombocythemia. Further, the company provides REPLAGAL for the treatment of Fabry disease; ELAPRASE for the treatment of hunter syndrome; VPRIV for the treatment of type 1 Gaucher disease; and FIRAZYR for the symptomatic treatment of acute attacks of hereditary angioedema. Additionally, it offers FOSRENOL for the treatment of hyperphosphatemia in end stage renal disease; XAGRID for the reduction of elevated platelet counts; and CINRYZE, a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema. The company also licenses its patented antiviral products for human immunodeficiency virus and hepatitis B virus. Shire plc markets its products directly to government hospitals, clinics, pharmacies, and other agencies; and through wholesalers and distributors. The company sells its products in North America, the United Kingdom, the Republic of Ireland, and internationally. Shire plc has research collaboration with Santaris Pharma A/S. The company was founded in 1986 and is headquartered in Dublin, Ireland.